Most Likely Diagnosis

Severe uncontrolled hypertension without identified acute target-organ injury

Differential Diagnosis

Hypertensive emergency
Medication nonadherence
White-coat effect
NSAID- or stimulant-associated hypertension
Primary hyperaldosteronism
Renovascular hypertension
Obstructive sleep apnea
Thyroid disease
Pheochromocytoma
Licorice-induced pseudohyperaldosteronism

Key Investigations

Depending on history and findings:

Repeat blood pressure using correct cuff size
Bilateral arm pressures
Urinalysis
Serum creatinine and electrolytes
Blood glucose or HbA1c
Lipid profile
ECG
Funduscopic examination
Troponin if ischemic symptoms are present
Chest imaging if pulmonary edema or aortic disease is suspected
Secondary-hypertension testing when indicated

Conventional Treatment

● Restart the previously tolerated medication if appropriate.
● Consider combination treatment when substantially above target.
● Common first-line medication groups include:
○ ACE inhibitor or ARB
○ Long-acting dihydropyridine calcium-channel blocker
○ Thiazide-type diuretic
● Investigate adherence, cost, adverse effects and dosing schedule.
● Treat contributing conditions such as sleep apnea, diabetes and kidney disease.
The current overarching treatment target is generally below 130/80 mm Hg, individualized for
clinical circumstances.

Naturopathic Treatment Plan

After dangerous causes have been excluded:

DASH- or Mediterranean-style dietary pattern
Reduced sodium intake
Gradual weight reduction
Regular aerobic and resistance activity
Limitation or avoidance of alcohol
Smoking cessation
Adequate sleep and treatment of sleep apnea
Home blood-pressure monitoring
Stress-management practices as adjuncts

These interventions supplement rather than replace necessary medication.

Botanical and Supplement Safety

● Avoid glycyrrhizin-containing licorice.
● Review stimulant products, pre-workout formulas, caffeine concentrates and
decongestants.
● Do not substitute garlic, green-tea extract or other supplements for prescribed treatment.
● Garlic supplements may increase bleeding risk in patients taking aspirin or
anticoagulants.
● Concentrated green-tea products can interact with cardiovascular medications.
Licorice may cause serious cardiovascular adverse effects, particularly in people with
hypertension, heart disease or kidney disease.

Monitoring

Home blood-pressure log
Symptoms of hypotension
Creatinine and potassium after ACE inhibitor, ARB or diuretic changes
Medication adherence
Follow-up within days rather than routine long-term follow-up alone

Urgent Referral Criteria

Immediate emergency assessment is required if severe blood pressure is associated with:

New neurological deficit
Confusion or seizure
Papilledema or acute visual loss
Chest pain or ischemic ECG changes

Acute pulmonary edema
Oliguria or acute renal dysfunction
Tearing chest or back pain
Pregnancy-related severe hypertension

Clinical Pearl

The presence of acute target-organ injury—not the blood-pressure value
alone—distinguishes hypertensive emergency from severe hypertension without acute
organ injury.

NPLEX Examination Trap

Do not select rapid blood-pressure normalization simply because the systolic pressure exceeds
180 mm Hg.

Disease Overview

Chronic hypertension damages the arterial system and increases the risk of coronary disease,
heart failure, atrial fibrillation, stroke, kidney disease and cognitive decline. Correct
measurement, adherence assessment and sustained risk-factor management are central to
treatment.

Most Likely Diagnosis

Chronic coronary disease presenting as stable exertional angina

Differential Diagnosis

Gastroesophageal reflux
Esophageal spasm
Costochondritis
Hypertrophic cardiomyopathy
Aortic stenosis
Microvascular angina
Pulmonary hypertension
Anemia
Exercise-induced bronchospasm

Key Investigations

Resting 12-lead ECG
CBC
Creatinine and electrolytes
HbA1c
Lipid profile
Consider thyroid testing
Echocardiogram if structural disease is suspected
Exercise ECG, stress imaging or coronary CT angiography according to pretest
probability and local pathways
● Coronary angiography when high-risk disease or refractory symptoms are suspected

Gold-Standard Investigation

There is no single investigation for every stable patient. Invasive coronary angiography
defines coronary anatomy but is not required as the first test in every person. Functional testing
or coronary CT angiography may be used initially depending on clinical risk.

Conventional Treatment

Treatment generally includes:

High-intensity statin therapy unless contraindicated
Blood-pressure and diabetes control
Antiplatelet therapy when clinically indicated
Antianginal therapy such as a beta-blocker, calcium-channel blocker or nitrate
Smoking cessation
Regular physical activity or cardiac rehabilitation
Revascularization when symptoms persist or anatomy indicates prognostic benefit

The 2023 chronic coronary disease guideline emphasizes patient-centred risk reduction,
lifestyle management and statins as first-line lipid-lowering treatment.

Naturopathic Treatment Plan

Once the patient has been medically evaluated:

Mediterranean-style dietary pattern
Increased vegetables, legumes, whole grains and unsalted nuts
Replacement of saturated fats with unsaturated fats
Gradual, supervised physical activity
Weight reduction when appropriate
Sleep-apnea assessment
Stress reduction and psychosocial support
Diabetes self-management
Medication-adherence counselling

Exercise should not be intensified until unstable disease and severe valvular disease have been
excluded.

Botanical and Supplement Safety

● Garlic, ginkgo and high-dose omega-3 supplements may increase bleeding concerns
when combined with antiplatelet or anticoagulant treatment.
● Concentrated green-tea products may reduce levels of atorvastatin or nadolol.
● Hawthorn should not be casually added to cardiac medication regimens because
efficacy and interaction information are limited.
● Supplements must not replace statins, antianginal therapy or revascularization
assessment.

Monitoring

Frequency, duration and triggers of angina
Resting symptoms
Exercise tolerance
Blood pressure
Lipids
HbA1c
Medication adverse effects
Need for rescue nitroglycerin
Evidence of heart failure

Urgent Referral Criteria

Call emergency services for:

Chest discomfort at rest
Increasing frequency or severity
Symptoms lasting more than several minutes
Syncope
Diaphoresis, vomiting or severe dyspnea
New ischemic ECG changes
Hemodynamic instability

Clinical Pearl

Predictable exertional symptoms suggest stable angina; new, accelerating or resting
symptoms suggest acute coronary syndrome.

NPLEX Examination Trap

Do not recommend an exercise program or botanical antianginal therapy before evaluating a
potentially ischemic chest-pain pattern.

Disease Overview

Chronic coronary disease results from atherosclerotic plaque and impaired coronary blood flow.
Management aims to reduce myocardial infarction, stroke and death while controlling symptoms
and improving functional capacity.

Most Likely Diagnosis

Acute inferior ST-elevation myocardial infarction

Differential Diagnosis

Aortic dissection
Pulmonary embolism
Acute pericarditis
Myocarditis
Tension pneumothorax
Esophageal rupture
Severe reflux or esophageal spasm

Key Investigations

Emergency evaluation includes:

Serial ECGs
Cardiac troponin
CBC
Electrolytes, creatinine and glucose

Coagulation studies
Chest radiograph when it will not delay reperfusion
Bedside echocardiography when complications are suspected
Right-sided ECG leads for suspected right ventricular infarction
Urgent coronary angiography

Gold-Standard Investigation

Urgent coronary angiography identifies the culprit lesion and permits percutaneous coronary
intervention.

Immediate Treatment Principles

Depending on contraindications and emergency protocols:

Activate EMS and reperfusion pathway
Aspirin
Additional antiplatelet treatment
Anticoagulation
Primary percutaneous coronary intervention
Continuous rhythm and hemodynamic monitoring
Oxygen only when hypoxemic or otherwise indicated
Careful nitrate use; avoid when hypotension, right ventricular infarction or
contraindicated medication use is present
● Treat cardiogenic shock and arrhythmias promptly
The 2025 acute coronary syndrome guideline integrates the emergency management of
unstable angina, NSTEMI and STEMI and emphasizes rapid evidence-based pharmacological
and invasive treatment.

Naturopathic Role

There is no primary naturopathic treatment during acute STEMI.
After stabilization and cardiac rehabilitation, adjunctive care may include:

Smoking cessation
Mediterranean-style nutrition
Weight management
Sleep optimization
Stress management
Supervised exercise
Medication-adherence support

Botanical and Supplement Safety

Stop nonessential supplements during acute assessment until interactions are reviewed.
Garlic, ginkgo and concentrated omega-3 products may affect bleeding risk.
Hawthorn has uncertain benefit and possible medication interactions.
Do not give supplements orally to an unstable or nauseated patient.
Never delay aspirin, reperfusion or emergency transfer for natural therapy.

Complications

Ventricular tachycardia or fibrillation
Bradycardia or heart block
Cardiogenic shock
Acute heart failure
Papillary-muscle rupture
Ventricular septal rupture
Free-wall rupture
Pericarditis
Ventricular aneurysm

Clinical Pearl

Time to reperfusion is myocardium.

NPLEX Examination Trap

Do not wait for troponin confirmation when the ECG and presentation already demonstrate
STEMI.

Disease Overview

STEMI usually results from acute coronary plaque disruption and thrombotic occlusion.
Myocardial necrosis progresses with time, so emergency reperfusion is the central treatment
priority.

Most Likely Diagnosis

Acute decompensated heart failure with reduced ejection fraction

Differential Diagnosis

Pneumonia
COPD exacerbation
Pulmonary embolism
Acute renal failure
Cirrhosis

● Nephrotic syndrome
● Severe anemia
● Constrictive pericarditis

Key Investigations

ECG
Chest radiograph
BNP or NT-proBNP
Troponin
CBC
Electrolytes, creatinine and liver enzymes
Glucose
Urinalysis
Echocardiography
Evaluation for infection, ischemia and arrhythmia

Conventional Acute Treatment

Hospital management may include:

Supplemental oxygen when hypoxemic
IV loop diuretic
Vasodilator therapy in selected hypertensive patients
Treatment of ischemia, infection or arrhythmia
Ventilatory support when needed
Monitoring of urine output, renal function and electrolytes

Long-Term HFrEF Treatment

Guideline-directed treatment commonly includes four foundational medication categories:
1. ARNI, ACE inhibitor or ARB
2. Evidence-based beta-blocker
3. Mineralocorticoid receptor antagonist
4. SGLT2 inhibitor
Additional treatment depends on symptoms, rhythm, renal function, iron status and device
indications. The 2022 guideline identifies these four medication classes as core HFrEF therapy.

Naturopathic Treatment Plan After Stabilization

Individualized sodium guidance
Daily weight monitoring
Appropriate fluid guidance
Mediterranean-style eating pattern
Supervised cardiac rehabilitation
Weight management
Sleep-apnea treatment
Smoking cessation
Recognition of early congestion
Medication-adherence support

Botanical and Supplement Safety

● Hawthorn should not be initiated casually in heart failure; long-term safety is not
established and medication interactions are possible.
● Licorice may worsen hypertension, fluid retention and potassium abnormalities.
● Avoid potassium supplements unless prescribed and monitored, especially with ACE
inhibitors, ARBs or mineralocorticoid antagonists.
● NSAIDs and certain over-the-counter products may worsen fluid retention.
● Review all supplements for renal and electrolyte effects.

Monitoring

Daily weight
Dyspnea and orthopnea
Edema
Blood pressure and heart rate
Creatinine
Sodium and potassium
Medication tolerance
Functional capacity

Urgent Referral Criteria

Resting dyspnea
Oxygen desaturation
New confusion
Hypotension
Chest pain
Rapid arrhythmia
Syncope
Pink frothy sputum

● Rapid weight gain with congestion
● Reduced urine output

Clinical Pearl

An increase in weight and orthopnea may indicate congestion before severe resting
respiratory distress develops.

NPLEX Examination Trap

Do not increase fluids automatically because the patient is taking a diuretic. First determine
whether the patient is volume depleted or congested.

Disease Overview

HFrEF is characterized by impaired ventricular systolic function. Neurohormonal activation
initially supports circulation but eventually promotes vasoconstriction, sodium retention and
ventricular remodelling.

Most Likely Diagnosis

Atrial fibrillation with rapid ventricular response

Differential Diagnosis

Atrial flutter with variable block
Multifocal atrial tachycardia
Frequent premature atrial complexes
Supraventricular tachycardia
Hyperthyroidism
Pulmonary embolism
Infection
Alcohol-related arrhythmia
Electrolyte abnormality

Key Investigations

12-lead ECG
CBC
Electrolytes, magnesium and creatinine
TSH
Glucose
Troponin when ischemia is suspected
Echocardiogram
Ambulatory monitoring when paroxysmal AF is suspected
Evaluation for sleep apnea, alcohol exposure and hypertension

Conventional Treatment

Depending on the patient:
● Beta-blocker or nondihydropyridine calcium-channel blocker for rate control
● Digoxin in selected clinical settings

Antiarrhythmic medication or cardioversion for rhythm control
Anticoagulation based on estimated thromboembolic risk
Catheter ablation in selected patients
Management of hypertension, obesity, sleep apnea, diabetes and alcohol exposure

The 2023 AF guideline emphasizes thromboembolic risk assessment, anticoagulation, lifestyle
and risk-factor modification, rhythm-control options and shared decision-making.

Naturopathic Treatment Plan

Adjunctive long-term measures include:

Weight reduction when indicated
Regular moderate exercise after medical clearance
Sleep-apnea diagnosis and treatment
Blood-pressure and diabetes management
Reduction of excessive alcohol intake
Smoking cessation
Adequate sleep
Review of stimulants and energy products

These measures do not convert acute AF reliably and must not replace rhythm, rate or
stroke-prevention treatment.

Botanical and Supplement Safety

Ginkgo may increase bleeding risk with warfarin or other anticoagulants.
Garlic supplements may increase bleeding risk with anticoagulants or aspirin.
Concentrated omega-3 supplements may affect clotting.
Hawthorn may cause dizziness and may interact with cardiac medications.
Stimulant botanicals and high-dose caffeine may aggravate palpitations.
Carefully document every supplement before anticoagulation is prescribed.

Urgent Referral Criteria

Hypotension or shock
Ongoing ischemic chest pain
Acute pulmonary edema
Syncope
Severe dyspnea
New neurological deficit
Pre-excited AF or very wide-complex tachycardia
Persistently very rapid ventricular rate

Clinical Pearl

In atrial fibrillation, address both the rhythm-related symptoms and the longer-term risk
of thromboembolic stroke.

NPLEX Examination Trap

A normal blood pressure does not make rapid AF benign.

Disease Overview

AF results from disorganized atrial electrical activation, causing ineffective atrial contraction and
an irregular ventricular response. Blood stasis, particularly in the left atrial appendage, can
promote thrombus formation and embolic stroke.

Differential Diagnosis

● Acute coronary syndrome
● Myocarditis or myopericarditis
● Pulmonary embolism

Pneumonia
Pleuritis
Aortic dissection
Gastroesophageal disease
Musculoskeletal chest pain

Key Investigations

ECG
Troponin
CBC
CRP or ESR
Renal function and electrolytes
Chest radiograph
Echocardiogram to evaluate effusion and tamponade
Cardiac MRI when myocarditis or uncertain inflammation is suspected
Etiological testing when tuberculosis, autoimmune disease, malignancy or bacterial
infection is suspected

Conventional Treatment

For uncomplicated presumed viral or idiopathic pericarditis:

Aspirin or an NSAID, when safe
Gastroprotection when appropriate
Colchicine as an adjunct
Restriction of strenuous physical activity
Monitoring of symptoms and inflammatory markers

Glucocorticoids are generally reserved for selected indications because they may increase
recurrence risk in some settings. The ESC identifies anti-inflammatory treatment with colchicine
as standard therapy for uncomplicated acute pericarditis, with evaluation for higher-risk
features.

High-Risk Features Requiring Hospital Assessment

Fever above 38°C
Large pericardial effusion
Cardiac tamponade
Subacute onset
Immunosuppression
Trauma
Anticoagulant therapy

● Elevated troponin suggesting myocardial involvement
● Failure to respond to appropriate treatment
● Suspected bacterial, tuberculous or malignant cause

Naturopathic Treatment Plan

Only after dangerous causes are excluded:

Rest during the active inflammatory phase
Adequate nutrition and hydration appropriate to cardiac status
Avoidance of intense exercise
Smoking cessation
Gradual return to activity after clinical resolution
Coordination with conventional treatment

No botanical product should replace anti-inflammatory treatment or echocardiographic
assessment.

Botanical and Supplement Safety

● Avoid combining multiple products with aspirin or NSAIDs without assessing bleeding
and gastrointestinal risk.
● Garlic, ginkgo and concentrated omega-3 products may add bleeding concerns.
● Avoid stimulant products when palpitations are present.
● Review renal function before recommending supplements cleared primarily through the
kidneys.

Complications

Recurrent pericarditis
Pericardial effusion
Cardiac tamponade
Myopericarditis
Constrictive pericarditis

Clinical Pearl

Positional pleuritic pain plus diffuse ST elevation strongly suggests pericarditis, but
myocardial infarction must still be actively excluded.

NPLEX Examination Trap

Do not assume all ST elevation is pericarditis because the patient is young or recently had a
viral illness.

Disease Overview

Pericarditis is inflammation of the pericardial layers. Viral or idiopathic disease is common, but
autoimmune, uremic, malignant, drug-related, bacterial and tuberculous causes must be
considered.

Most Likely Diagnosis

Infective endocarditis
Potential organisms depend on valve status, exposures and healthcare history. In injection-drug
use, Staphylococcus aureus is particularly important.

Differential Diagnosis

● Sepsis from another source
● Nonbacterial thrombotic endocarditis

Systemic lupus erythematosus
Vasculitis
Occult malignancy
Tuberculosis
Atrial myxoma
Rheumatic fever

Key Investigations

Multiple blood-culture sets from separate venipuncture sites
CBC
CRP and ESR
Renal and liver function
Urinalysis
ECG
Transthoracic echocardiography
Transesophageal echocardiography when indicated
Imaging for embolic complications
Testing for HIV, hepatitis and other exposure-related infections when appropriate

Gold-Standard Diagnostic Approach

Diagnosis combines:

Microbiological evidence
Echocardiographic or other imaging evidence
Predisposing factors
Clinical vascular and immunological findings

Transesophageal echocardiography is more sensitive than transthoracic imaging for many
vegetations, prosthetic valves and periannular complications.

Conventional Treatment

Urgent hospital admission
Prolonged targeted IV antimicrobial therapy
Infectious-disease and cardiology involvement
Surgical consultation when there is:
○ Heart failure from valve dysfunction
○ Uncontrolled infection
○ Abscess
○ Recurrent embolization or large high-risk vegetation
○ Prosthetic-valve or device complications

The 2023 ESC guideline emphasizes coordinated endocarditis-team care, blood cultures,
multimodality imaging, antimicrobial treatment and timely surgery when indicated.

Naturopathic Role

There is no appropriate stand-alone naturopathic treatment for active infective endocarditis.
Adjunctive care during recovery may address:

Nutrition
Substance-use treatment
Oral hygiene after stabilization
Smoking cessation
Medication adherence
Rehabilitation
Psychosocial support

Adjuncts must be coordinated with the hospital team.

Botanical and Supplement Safety

● Avoid unreviewed supplements during acute antimicrobial therapy.
● Herb–drug interactions may alter antibiotic, anticoagulant or cardiac medication
exposure.
● Garlic, ginkgo and high-dose omega-3 products may complicate bleeding management.
● Probiotic use, if considered, must be individualized in severely ill or
immunocompromised patients.
● Do not delay antibiotics for cultures when the patient is unstable.

Complications

Valve destruction and acute heart failure
Septic emboli
Stroke
Mycotic aneurysm
Splenic or renal infarction
Glomerulonephritis
Conduction block from abscess
Persistent sepsis
Death

Clinical Pearl

Unexplained fever plus a new murmur should be treated as infective endocarditis until
appropriately investigated.

NPLEX Examination Trap

Do not prescribe immune-stimulating herbs for prolonged fever before excluding serious
bacterial infection.

Disease Overview

Infective endocarditis is microbial infection of the endocardial surface, usually involving a valve
or implanted cardiac material. Vegetations can destroy tissue and embolize to distant organs.

Most Likely Diagnosis

Chronic symptomatic lower-extremity peripheral artery disease with intermittent
claudication

Differential Diagnosis

Lumbar spinal stenosis
Peripheral neuropathy
Chronic venous disease
Osteoarthritis
Muscular strain
Popliteal cyst
Chronic exertional compartment syndrome

Key Investigations

Resting ABI
Exercise ABI if resting results are normal but symptoms remain suggestive
Toe-brachial index when arteries are noncompressible
Duplex ultrasound
CT or MR angiography when revascularization is considered
Lipid profile
HbA1c
Renal function
Foot and skin assessment

Conventional Treatment

Smoking cessation
Structured or supervised exercise therapy
High-intensity statin therapy when tolerated
Antiplatelet therapy for symptomatic PAD
Blood-pressure and diabetes management
Cilostazol for selected patients without heart failure
Revascularization when symptoms remain lifestyle-limiting despite optimal therapy
Urgent vascular management for limb-threatening ischemia

The 2024 PAD guideline classifies asymptomatic PAD, chronic symptomatic PAD, chronic
limb-threatening ischemia and acute limb ischemia and emphasizes multidisciplinary
cardiovascular and limb-risk management.

Naturopathic Treatment Plan

Structured interval walking
Mediterranean-style dietary pattern
Smoking-cessation support
Glycemic management
Weight management
Daily foot inspection
Protective footwear
Prompt treatment of skin injury
Avoidance of extreme heat directly on an ischemic foot

Botanical and Supplement Safety

● Ginkgo has not demonstrated a reliable clinically important benefit for claudication and
may increase bleeding risk with anticoagulants.
● Garlic supplements may also increase bleeding risk.
● Avoid products promoted as alternatives to antiplatelet or statin treatment.
● Review supplements before vascular procedures.
● Avoid aggressive manipulation or deep tissue work in areas with ulcers, fragile tissue or
poor perfusion.

Urgent Referral Criteria

Features of acute limb ischemia include:

Sudden pain
Pallor
Pulselessness
Paresthesia
Paralysis
Poikilothermia or marked coolness

Chronic limb-threatening ischemia may present with rest pain, nonhealing ulcer or gangrene.

Clinical Pearl

Claudication is a marker of systemic atherosclerosis, not merely a local leg problem.

NPLEX Examination Trap

Do not advise a patient with stable claudication to avoid all walking. Structured exercise is
therapeutic.

Disease Overview

PAD is usually caused by lower-extremity atherosclerosis. It increases the risks of myocardial
infarction, stroke, amputation and cardiovascular death.

Most Likely Diagnosis

Symptomatic severe calcific aortic stenosis

Differential Diagnosis

Hypertrophic obstructive cardiomyopathy
Chronic coronary disease
Pulmonary hypertension
Heart failure
Arrhythmia
Carotid sinus disease
Orthostatic hypotension
Anemia

Key Investigations

Transthoracic echocardiogram
ECG
CBC
Renal function and electrolytes
Chest radiograph
Coronary assessment before intervention when indicated
Exercise testing only in carefully selected asymptomatic patients under supervision
CT assessment for transcatheter valve planning

Gold-Standard Assessment

Comprehensive echocardiography is the principal noninvasive diagnostic test. Cardiac
catheterization may be required when noninvasive findings are discordant or coronary anatomy
must be defined.

Conventional Treatment

● Referral to a multidisciplinary valve team
● Surgical aortic-valve replacement or transcatheter aortic-valve implantation according to
anatomy, age, surgical risk and patient preference
● Management of associated hypertension, coronary disease, AF and heart failure
● Cautious medication use because no medication reverses severe mechanical valve
obstruction
ACC/AHA guidance bases intervention for severe aortic stenosis primarily on symptoms or
impaired ventricular systolic function and recommends multidisciplinary valve-centre evaluation
for severe disease.

Naturopathic Role

Before valve treatment:

Avoid strenuous unsupervised exertion
Maintain appropriate hydration while avoiding fluid overload
Address nutrition and frailty
Support smoking cessation
Review fall risk
Coordinate all interventions with cardiology

After intervention:

Cardiac rehabilitation
Heart-healthy diet
Medication and anticoagulation adherence where applicable
Dental and infection-prevention guidance
Monitoring for recurrent symptoms

Botanical and Supplement Safety

● Avoid licorice.
● Avoid aggressive vasodilating or diuretic supplements in patients with presyncope or low
blood pressure.
● Review garlic, ginkgo and omega-3 products before procedures or when antithrombotic
therapy is used.
● No botanical treatment removes calcification or replaces valve intervention.

Urgent Referral Criteria

Syncope
Resting chest pain
Pulmonary edema
Hypotension
Worsening dyspnea
New arrhythmia
Signs of low cardiac output

Clinical Pearl

Angina, syncope and dyspnea are the classic symptomatic triad of advanced aortic
stenosis.

NPLEX Examination Trap

Do not recommend vigorous exercise for exertional syncope before excluding severe valvular
obstruction.

Disease Overview

Aortic stenosis produces fixed obstruction to left-ventricular outflow. The ventricle initially
compensates through hypertrophy, but progressive disease leads to ischemia, diastolic
dysfunction, heart failure and reduced cardiac output.

Most Likely Diagnosis

Acute aortic dissection, likely Stanford type A
Ascending-aortic involvement is suggested by the new aortic-regurgitation murmur and
neurological findings.

Differential Diagnosis

Acute coronary syndrome
Pulmonary embolism
Acute pericarditis
Tension pneumothorax
Esophageal rupture
Musculoskeletal thoracic pain
Acute pancreatitis

Key Investigations

● CT angiography of the aorta in a stable patient
● Transesophageal echocardiography when unstable or CT is impractical
● MRI in selected stable situations

ECG
Troponin
CBC
Creatinine and electrolytes
Coagulation studies
Type and crossmatch
Bedside echocardiography for tamponade or aortic regurgitation

Gold-Standard Investigation

CT angiography is commonly the first definitive investigation in a stable patient because it
rapidly defines the extent, branch involvement and complications.

Immediate Conventional Treatment

Emergency transfer
Continuous monitoring
IV analgesia
Rapid reduction of aortic-wall shear using IV beta-blockade when appropriate
Additional blood-pressure control after heart-rate control
Immediate cardiothoracic surgical evaluation for type A dissection
Endovascular or medical management for selected uncomplicated type B disease
Management of tamponade, rupture and organ malperfusion

Aortic-disease guidelines emphasize standardized CT, MRI and echocardiographic imaging and
rapid specialist management of acute aortic syndromes.

Naturopathic Role

There is no acute naturopathic treatment for aortic dissection.
After repair and stabilization, adjunctive management may include:

Strict blood-pressure adherence
Smoking cessation
Heart-healthy nutrition
Avoidance of heavy isometric lifting
Appropriate rehabilitation
Family or genetic evaluation when indicated
Lifelong imaging surveillance
Medication and follow-up adherence

Botanical and Supplement Safety

Avoid stimulant products that elevate blood pressure or heart rate.
Avoid licorice.
Do not administer anticoagulant or antiplatelet supplements reflexively for chest pain.
Avoid deep massage or spinal manipulation before vascular emergencies have been
excluded.
● Review all supplements that may interfere with antihypertensives or antithrombotic
therapy.

Complications

Aortic rupture
Cardiac tamponade
Severe aortic regurgitation
Myocardial infarction
Stroke
Spinal-cord ischemia
Renal or mesenteric ischemia
Acute limb ischemia
Death

Clinical Pearl

Abrupt maximal pain plus a pulse or neurological deficit is an aortic dissection until
proven otherwise.

NPLEX Examination Trap

Do not diagnose musculoskeletal back pain and perform manipulation when the presentation
includes sudden severe pain, vascular asymmetry or neurological findings.

Disease Overview

Aortic dissection occurs when blood enters the aortic media through an intimal tear or related
wall injury, creating a false lumen. Ascending-aortic disease generally requires emergency
surgery because of the risks of rupture, tamponade and coronary or cerebral involvement.

NPLEX 2 — System-Based Clinical Review

Cardiovascular Cases 11–20

Most Likely Diagnosis

Acute pulmonary embolism arising from lower-extremity deep-vein thrombosis

Differential Diagnosis

Acute coronary syndrome
Pneumonia
Pneumothorax
Acute pericarditis
Aortic dissection
Asthma exacerbation
Pleuritis
Musculoskeletal chest pain
Panic attack

Key Investigations

Clinical pretest-probability assessment
D-dimer in appropriately selected lower-risk patients
CT pulmonary angiography
Ventilation-perfusion scanning when CT contrast is unsuitable
Compression ultrasonography of the symptomatic leg
ECG
CBC
Creatinine and electrolytes
Coagulation studies
Troponin and natriuretic peptide for risk stratification
Echocardiography when right-heart strain or hemodynamic compromise is suspected

D-dimer is most useful when pretest probability is sufficiently low or intermediate. A positive
D-dimer is nonspecific and usually requires definitive imaging.

Gold-Standard or Confirmatory Investigation

CT pulmonary angiography is the usual definitive imaging study in a hemodynamically stable
patient.

Conventional Treatment

Treatment depends on severity and may include:
● Anticoagulation
● Oxygen when hypoxemic
● Hemodynamic and cardiac monitoring

● Thrombolytic therapy for selected patients with circulatory failure or high-risk
deterioration
● Catheter-directed intervention or surgical embolectomy in selected severe cases
● Evaluation of reversible and persistent risk factors
Direct oral anticoagulants are preferred for many eligible patients. The duration of treatment
depends on whether the event was provoked, unprovoked, recurrent or associated with a
persistent risk factor. The 2026 guideline recommends considering extended anticoagulation
after a first PE without a major reversible risk factor or in the presence of a persistent risk factor.

Naturopathic Treatment Plan

There is no stand-alone naturopathic treatment for acute pulmonary embolism.
After medical stabilization:

Encourage gradual return to activity as medically directed.
Address obesity, smoking and sedentary behaviour.
Review hormonal and medication-related risk factors.
Counsel the patient regarding anticoagulant adherence.
Support appropriate hydration during future prolonged travel.
Encourage movement and calf-muscle activation during extended travel.
Monitor for persistent dyspnea or exercise intolerance.

Botanical and Supplement Safety

● Garlic, ginkgo and concentrated omega-3 products may increase bleeding concerns
during anticoagulation.
● Avoid combining anticoagulants with high-dose salicylate-containing herbs without
clinical review.
● Avoid natto or concentrated vitamin K products when a patient is taking warfarin unless
intake is consistent and supervised.
● Do not use serrapeptase, nattokinase or similar products as replacements for
anticoagulation.
● Review all supplements before starting or changing anticoagulant treatment.

Monitoring

Signs of bleeding
Recurrent chest pain or dyspnea
Oxygenation
Renal and hepatic function
Platelet count when clinically appropriate

● Anticoagulant adherence
● Drug and supplement interactions
● Persistent exercise limitation
Patients should be assessed for ongoing symptoms and functional limitations after PE to detect
chronic thromboembolic pulmonary disease or another cause of persistent dyspnea.

Urgent Referral Criteria

Hypotension
Syncope
Severe hypoxemia
Altered mental status
Cyanosis
Marked respiratory distress
Evidence of right-heart failure
Cardiac arrest
Significant active bleeding

Clinical Pearl

Clear lungs do not exclude pulmonary embolism.

NPLEX Examination Trap

Do not diagnose anxiety solely because a patient has tachycardia, chest discomfort and a
relatively normal pulmonary examination.

Disease Overview

Pulmonary embolism usually results from migration of a thrombus from a deep vein into the
pulmonary arteries. Obstruction and pulmonary vasoconstriction increase right-ventricular
afterload and may cause right-heart failure, hypoxemia, shock and death.

Most Likely Diagnosis

Acute proximal lower-extremity deep-vein thrombosis provoked by surgery and
immobility

Differential Diagnosis

Cellulitis
Ruptured Baker cyst
Superficial thrombophlebitis
Lymphedema
Chronic venous insufficiency
Muscle injury
Compartment syndrome
Heart-failure-associated edema

Key Investigations

Compression duplex ultrasonography
Clinical pretest-probability assessment
D-dimer in selected patients
CBC
Creatinine
Liver tests when relevant to anticoagulant selection
Coagulation studies
Evaluation for pulmonary embolism if cardiopulmonary symptoms develop

Gold-Standard or Confirmatory Investigation

Compression ultrasonography is the standard initial imaging test.
Contrast venography can demonstrate venous obstruction but is invasive and rarely required in
routine clinical practice.

Conventional Treatment

Treatment usually includes:

Therapeutic anticoagulation
Assessment of bleeding risk
Appropriate mobilization once treatment is initiated and the patient is clinically stable
Compression therapy in selected patients for symptom management
Review of reversible provoking factors
Education about pulmonary-embolism symptoms

For most patients with DVT or PE, the primary treatment phase is at least three months.
Duration is individualized according to whether the event was provoked, unprovoked, recurrent
or associated with persistent risk factors.

Naturopathic Treatment Plan

Naturopathic care is supportive and must not replace anticoagulation.
Appropriate measures may include:

Smoking cessation
Gradual return to mobility under medical direction
Weight management
Prevention of prolonged immobility
Adequate hydration when appropriate
Nutrition supporting overall cardiovascular health
Education regarding anticoagulant adherence
Skin and edema monitoring

Botanical and Supplement Safety

● Do not recommend forceful massage over a suspected or confirmed acute DVT.
● Avoid unmonitored garlic, ginkgo, high-dose ginger, turmeric extracts and concentrated
omega-3 products while anticoagulated.
● Do not replace anticoagulation with nattokinase or “natural blood-thinning” products.
● Review vitamin K intake if warfarin is used.
● Consider renal and hepatic function before recommending supplements.

Monitoring

Leg swelling and pain
Signs of pulmonary embolism
Bleeding or bruising
Hemoglobin and platelet count when appropriate
Renal function
Medication adherence
Post-thrombotic symptoms
Need for treatment extension

Urgent Referral Criteria

Immediate assessment is required for:

New dyspnea
Pleuritic chest pain
Syncope
Hemoptysis
Hypoxemia
Severe whole-leg swelling
Cyanosis
Threatened limb viability
Significant anticoagulant-related bleeding

Clinical Pearl

D-dimer is less useful after surgery because tissue injury commonly elevates it even
when DVT is absent.

NPLEX Examination Trap

Do not use a negative Homans sign to exclude DVT. It is neither sufficiently sensitive nor
specific.

Disease Overview

DVT is thrombus formation within a deep vein, most commonly in the lower extremity. Venous
stasis, endothelial injury and hypercoagulability constitute the classic Virchow triad.

Most Likely Diagnosis

Paroxysmal supraventricular tachycardia, likely AV nodal re-entrant tachycardia

Differential Diagnosis

Atrioventricular re-entrant tachycardia
Atrial tachycardia
Atrial flutter with fixed conduction
Sinus tachycardia
Junctional tachycardia
Atrial fibrillation
Ventricular tachycardia with a narrow-appearing complex

Key Investigations

● 12-lead ECG during symptoms
● Repeat ECG after conversion
● Electrolytes

Magnesium
CBC
TSH when clinically indicated
Pregnancy testing when relevant to treatment selection
Echocardiography if structural disease is suspected
Ambulatory rhythm monitoring
Electrophysiology study when ablation is considered

Conventional Treatment

Acute Stable SVT

Modified Valsalva manoeuvre
IV adenosine when appropriate
Beta-blocker or nondihydropyridine calcium-channel blocker in selected cases
Synchronized cardioversion when medication is ineffective or instability develops

Long-Term Management

Education about safe vagal techniques
Reduction of identifiable triggers
Pharmacological suppression in selected patients
Catheter ablation for recurrent, symptomatic or patient-preferred definitive management

Naturopathic Treatment Plan

After the arrhythmia has been evaluated:

Reduce excessive caffeine and energy drinks.
Avoid stimulant pre-workout products.
Maintain regular sleep.
Address anxiety without assuming anxiety is the primary cause.
Maintain hydration and regular meals.
Treat thyroid disease, anemia or other contributing disorders.
Use symptom and trigger diaries.

Botanical and Supplement Safety

Avoid ephedra-like stimulants, bitter orange, yohimbe and high-dose caffeine.
Avoid unmonitored potassium or magnesium supplementation.
Review decongestants and weight-loss supplements.
Hawthorn should not replace rhythm evaluation.

● Licorice may cause hypokalemia and increase arrhythmia risk.
● Supplement use must be reviewed when beta-blockers or calcium-channel blockers are
prescribed.

Urgent Referral Criteria

Hypotension
Syncope
Ongoing ischemic chest discomfort
Pulmonary edema
Altered mental status
Severe dyspnea
Wide-complex rhythm
Known pre-excitation with an irregular tachycardia

Clinical Pearl

A sudden-onset, sudden-offset, regular narrow-complex tachycardia strongly suggests a
re-entrant SVT.

NPLEX Examination Trap

Do not label every rapid heart rate as anxiety or sinus tachycardia without examining rhythm
regularity and ECG morphology.

Disease Overview

Re-entrant SVT results from an electrical circuit that repeatedly activates atrial or atrioventricular
nodal tissue. AV nodal re-entry is one of the most common mechanisms in otherwise healthy
adults.

Most Likely Diagnosis

Hemodynamically unstable sustained monomorphic ventricular tachycardia

Differential Diagnosis

SVT with aberrant conduction
Antidromic atrioventricular re-entrant tachycardia
Paced rhythm
Hyperkalemia-related wide-complex tachycardia
Sodium-channel-blocker toxicity
Torsades de pointes

Key Investigations

After immediate stabilization:

Serial ECGs
Troponin
Electrolytes
Magnesium
Calcium
Renal and hepatic function
Toxicology and medication review
Echocardiography
Coronary assessment when ischemia is suspected
Cardiac MRI in selected patients

● Electrophysiology evaluation

Conventional Treatment

Immediate synchronized cardioversion
Airway and circulatory support
Antiarrhythmic therapy according to rhythm and clinical context
Correction of electrolyte disturbances
Treatment of acute ischemia
Evaluation for implantable cardioverter-defibrillator therapy
Catheter ablation in selected recurrent cases
Guideline-directed therapy for underlying cardiomyopathy or coronary disease

Naturopathic Role

There is no appropriate acute naturopathic treatment.
After stabilization:

Support medication adherence.
Promote cardiac rehabilitation.
Avoid stimulant substances.
Support smoking cessation.
Encourage heart-healthy nutrition.
Address sleep apnea.
Help the patient recognize warning symptoms.
Coordinate every supplement with cardiology.

Botanical and Supplement Safety

Products that may contribute to tachyarrhythmia include:

Ephedra-type stimulants
Bitter orange
Yohimbe
Concentrated caffeine
Licorice
Products contaminated with sympathomimetics
Unmonitored electrolyte supplements

Review agents that prolong the QT interval or alter antiarrhythmic metabolism.

Urgent Referral Criteria

All sustained suspected ventricular tachycardia requires urgent medical assessment. Immediate
resuscitative treatment is required with:

Hypotension
Altered mental status
Ischemic chest pain
Acute heart failure
Syncope
Loss of pulse

Clinical Pearl

A regular wide-complex tachycardia in a patient with structural heart disease is
ventricular tachycardia until proven otherwise.

NPLEX Examination Trap

Do not delay cardioversion while attempting to identify the exact mechanism of an unstable
wide-complex rhythm.

Disease Overview

Ventricular tachycardia originates below the atrioventricular node. Scar from previous
myocardial infarction commonly creates a re-entry circuit. Sustained VT can rapidly deteriorate
into ventricular fibrillation or cardiac arrest.

Most Likely Diagnosis

Symptomatic complete atrioventricular block, potentially worsened by beta-blocker
toxicity

Differential Diagnosis

Second-degree AV block
Severe sinus-node dysfunction
Hyperkalemia
Acute inferior myocardial infarction
Lyme carditis
Myocarditis
Digoxin toxicity
Calcium-channel-blocker toxicity
Infiltrative cardiac disease

Key Investigations

Continuous cardiac monitoring
Serial ECGs
Electrolytes, including potassium
Magnesium and calcium
Creatinine
Glucose
Troponin
Medication levels when relevant
TSH in selected cases
Lyme testing when epidemiologically appropriate
Echocardiography

● Evaluation for myocardial ischemia

Conventional Treatment

● Stop causative AV-nodal-blocking medication.
● Provide emergency monitoring.
● Administer atropine in appropriate symptomatic bradycardia, recognizing that high-grade
infranodal block may not respond.
● Initiate transcutaneous pacing when necessary.
● Arrange transvenous pacing if instability persists.
● Treat medication toxicity, ischemia or electrolyte disturbance.
● Implant a permanent pacemaker when indicated.

Naturopathic Role

There is no stand-alone naturopathic treatment for complete heart block.
After stabilization:

Conduct medication-reconciliation counselling.
Review pill-organizer use.
Address fall risk.
Encourage appropriate hydration and nutrition.
Review all products that lower heart rate or blood pressure.
Support follow-up after pacemaker insertion.

Botanical and Supplement Safety

Potentially problematic products include:

Hawthorn with cardiac medications
Excessive magnesium in renal impairment
Licorice causing hypokalemia
Stimulant products used to “correct” bradycardia
Sedative combinations that worsen dizziness or falls

No supplement should be used to delay pacing.

Urgent Referral Criteria

● Syncope
● Hypotension

Chest pain
Heart failure
Altered mental status
Ventricular escape rhythm
Pauses
Evidence of acute myocardial infarction
Progressive conduction block

Clinical Pearl

Complete heart block is identified by atrioventricular dissociation, not merely a slow
heart rate.

NPLEX Examination Trap

Do not recommend exercise or stimulant supplements to raise the pulse in a patient with
symptomatic conduction disease.

Disease Overview

Complete AV block occurs when atrial impulses fail to conduct to the ventricles. Ventricular
activity depends on a slower escape pacemaker, which may be unreliable and unable to
maintain adequate cardiac output.

Most Likely Diagnosis

Obstructive hypertrophic cardiomyopathy

Differential Diagnosis

Aortic stenosis
Athlete’s heart
Anomalous coronary artery
Arrhythmogenic cardiomyopathy
Myocarditis
Dilated cardiomyopathy
Vasovagal syncope
Exercise-induced asthma

Key Investigations

Transthoracic echocardiography
ECG
Ambulatory rhythm monitoring
Exercise testing under specialist supervision
Cardiac MRI
Family history extending over several generations
Genetic counselling and testing when appropriate
Screening of first-degree relatives
Assessment of maximal wall thickness, outflow gradient and ventricular function

Gold-Standard Diagnostic Approach

Diagnosis is based primarily on cardiac imaging showing otherwise unexplained left-ventricular
hypertrophy.
Cardiac MRI is valuable when echocardiography is inconclusive or additional characterization,
including myocardial fibrosis, is required.

Conventional Treatment

Management may include:

● Nonvasodilating beta-blocker for symptomatic obstructive HCM
● Verapamil or diltiazem in selected patients
● Myosin-inhibitor therapy, disopyramide or septal-reduction therapy for persistent
obstructive symptoms
● Implantable cardioverter-defibrillator for selected patients at increased sudden-death risk
● Treatment of atrial fibrillation
● Family screening
● Individualized advice about sports and exercise
The 2024 guideline incorporates cardiac myosin inhibition as an option for selected symptomatic
obstructive disease when first-line treatment is inadequate.

Naturopathic Treatment Plan

Adjunctive measures include:

Maintain appropriate hydration.
Avoid sudden volume depletion.
Avoid extreme heat exposure.
Avoid unapproved high-intensity exercise until evaluated.
Support healthy sleep and stress management.
Avoid stimulant energy products.
Educate family members about screening.
Coordinate all supplements with an HCM specialist.

Botanical and Supplement Safety

Use caution with:

Diuretic herbs
Potent vasodilators
Stimulant products
Yohimbe
Bitter orange
High-dose caffeine
Licorice
Products causing vomiting or dehydration

These can worsen obstruction, arrhythmia or blood-pressure instability.

Urgent Referral Criteria

● Exertional syncope or presyncope

Sustained palpitations
Chest pain
Family history of premature sudden death
Documented ventricular arrhythmia
Acute heart failure
New atrial fibrillation
Resuscitated cardiac arrest

Clinical Pearl

The murmur of obstructive HCM becomes louder when preload decreases.

NPLEX Examination Trap

Do not assume left-ventricular hypertrophy in an athlete is always a benign training adaptation.

Disease Overview

HCM is commonly a genetic myocardial disorder characterized by unexplained ventricular
hypertrophy. Dynamic outflow obstruction, diastolic dysfunction, myocardial ischemia and
arrhythmias contribute to symptoms and sudden-death risk.

Most Likely Diagnosis

Acute myocarditis with ventricular dysfunction and ventricular ectopy

Differential Diagnosis

Acute coronary syndrome
Stress cardiomyopathy
Acute pericarditis
Dilated cardiomyopathy
Cardiac sarcoidosis
Giant-cell myocarditis
Drug-induced myocarditis
Lyme carditis
Sepsis-related cardiomyopathy

Key Investigations

Serial ECGs
Serial troponin
BNP or NT-proBNP
CBC
CRP or ESR
Electrolytes and renal function
Echocardiography
Cardiac MRI
Coronary imaging when acute coronary syndrome cannot be excluded
Endomyocardial biopsy in selected high-risk cases
Testing for specific infectious, immune or toxic causes when clinically indicated

Gold-Standard or Confirmatory Investigation

Endomyocardial biopsy provides histological diagnosis, but it is not required for every patient.
Cardiac MRI is the principal noninvasive test for identifying myocardial inflammation, edema and
injury patterns.

Conventional Treatment

Management depends on presentation:
● Hospital monitoring when arrhythmia or ventricular dysfunction is present

Guideline-directed heart-failure treatment
Management of ventricular arrhythmias
Mechanical circulatory support in fulminant disease
Cause-specific therapy in selected immune-mediated, infectious or toxic cases
Restriction of strenuous activity until clinical remission and specialist clearance
Follow-up imaging and rhythm assessment

Naturopathic Treatment Plan

During active myocarditis:

Avoid exercise and strenuous physical activity.
Avoid alcohol and recreational stimulants.
Maintain nutrition appropriate to heart-failure status.
Avoid excessive sodium if congestion is present.
Prioritize sleep and recovery.
Do not initiate numerous supplements during active myocardial injury.
Coordinate all adjunctive care with cardiology.

Botanical and Supplement Safety

Avoid:

Stimulants
Sympathomimetic weight-loss products
Licorice
High-dose minerals without electrolyte testing
Botanicals that interact with heart-failure or antiarrhythmic drugs
Products marketed as immune stimulants without knowing the cause of myocardial
inflammation

Unsupervised immune stimulation may be inappropriate in immune-mediated myocarditis.

Urgent Referral Criteria

Syncope
Sustained ventricular arrhythmia
Hypotension
Acute pulmonary edema
Rising troponin with instability
New conduction block
Severe ventricular dysfunction
Cardiogenic shock

● Cardiac arrest

Clinical Pearl

Myocarditis can imitate myocardial infarction, but ventricular dysfunction may be global
rather than confined to one coronary territory.

NPLEX Examination Trap

Do not recommend exercise to overcome postviral fatigue until myocarditis has been excluded
when chest discomfort, palpitations or elevated troponin are present.

Disease Overview

Myocarditis is inflammatory injury of the myocardium caused by infectious, immune-mediated,
toxic or other processes. Injury may resolve completely or progress to chronic inflammatory
cardiomyopathy and heart failure.

Most Likely Diagnosis

Symptomatic severe primary degenerative mitral regurgitation

Differential Diagnosis

Functional secondary mitral regurgitation
Ventricular septal defect
Tricuspid regurgitation
Aortic stenosis
Hypertrophic cardiomyopathy
Dilated cardiomyopathy
Ischemic heart disease

Key Investigations

Transthoracic echocardiography
Transesophageal echocardiography when anatomy needs clarification
ECG
Chest radiograph
BNP or NT-proBNP
Ambulatory monitoring when palpitations occur
Exercise testing in selected apparently asymptomatic patients
Coronary evaluation before intervention when indicated
Serial measurement of left-ventricular size and function

Gold-Standard Assessment

Comprehensive Doppler echocardiography establishes mechanism, severity, ventricular
response and pulmonary pressures.
Transesophageal echocardiography provides detailed anatomy for repair planning.

Conventional Treatment

Referral to a valve centre
Mitral-valve repair when feasible
Valve replacement when repair is unsuitable
Diuretics for congestion
Treatment of hypertension
Management of atrial fibrillation
Anticoagulation when indicated

● Monitoring of ventricular function and pulmonary pressure

Naturopathic Treatment Plan

Adjunctive care may include:

Sodium moderation when congested
Daily weight monitoring
Appropriate physical activity after medical guidance
Smoking cessation
Mediterranean-style nutrition
Sleep-apnea evaluation
Medication-adherence support
Dental and oral-health maintenance
Rehabilitation after intervention

Botanical and Supplement Safety

Avoid strong unmonitored diuretic combinations.
Monitor potassium when prescription diuretics are used.
Avoid licorice in hypertension or fluid retention.
Review garlic, ginkgo and concentrated omega-3 products before surgery or during
anticoagulation.
● Hawthorn does not repair a flail valve.
● Do not postpone valve intervention in favour of supplements.

Urgent Referral Criteria

Resting dyspnea
Pulmonary edema
New atrial fibrillation
Syncope
Hypotension
Rapid decline in exercise capacity
Evidence of declining ventricular function
Acute MR after myocardial infarction or chordal rupture

Clinical Pearl

Chronic severe mitral regurgitation may maintain a normal or apparently high ejection
fraction until ventricular dysfunction is advanced.

NPLEX Examination Trap

Do not interpret a preserved ejection fraction as proof that severe mitral regurgitation is
harmless.

Disease Overview

Mitral regurgitation permits systolic blood flow from the left ventricle into the left atrium. Chronic
volume overload causes left-atrial and ventricular dilation, atrial fibrillation, pulmonary
hypertension and eventual heart failure.

Most Likely Diagnosis

Ruptured abdominal aortic aneurysm with hemorrhagic shock

Differential Diagnosis

● Aortic dissection
● Acute myocardial infarction

Mesenteric ischemia
Perforated viscus
Renal colic
Acute pancreatitis
Retroperitoneal hemorrhage
Massive gastrointestinal bleeding

Key Investigations

Investigation must not delay lifesaving treatment.
Possible emergency studies include:

Bedside aortic ultrasound
CT angiography when the patient is sufficiently stable
CBC
Electrolytes and creatinine
Coagulation studies
Lactate
Blood gas
Type and crossmatch
ECG
Troponin

Gold-Standard Investigation

CT angiography defines aneurysm anatomy and rupture in a sufficiently stable patient.
In a profoundly unstable patient with classic findings, immediate operative management may be
necessary without waiting for CT.

Conventional Treatment

Activate massive-hemorrhage and vascular-surgery pathways.
Establish large-bore vascular access.
Prepare blood products.
Use balanced resuscitation.
Avoid excessive elevation of blood pressure before hemorrhage control.
Proceed to emergency endovascular or open repair.
Correct coagulopathy, hypothermia and acidosis.
Provide intensive postoperative monitoring.

Naturopathic Role

There is no acute naturopathic treatment for a ruptured aneurysm.
Following successful repair:

Smoking cessation
Blood-pressure control
Lipid and cardiovascular-risk management
Appropriate rehabilitation
Medication adherence
Surveillance imaging
Nutrition supporting recovery
Avoidance of unapproved heavy lifting

Botanical and Supplement Safety

Do not administer oral products to a shocked patient.
Avoid garlic, ginkgo and concentrated omega-3 products before emergency surgery.
Avoid stimulant products that raise blood pressure.
Avoid licorice.
Review all anticoagulant or antiplatelet supplements after stabilization.
No botanical product can shrink or repair a ruptured aneurysm.

Urgent Referral Criteria

Every suspected symptomatic or ruptured aneurysm requires emergency referral, particularly
with:

Sudden abdominal or back pain
Hypotension
Syncope
Pulsatile abdominal mass
New limb ischemia
Rapidly falling hemoglobin
Shock

Clinical Pearl

The classic triad is abdominal or back pain, hypotension and a pulsatile abdominal mass,
but all three are not always present.

NPLEX Examination Trap

Do not wait for complete classic findings before arranging emergency treatment.

Disease Overview

An abdominal aortic aneurysm is pathological dilation of the abdominal aorta. Rupture causes
massive retroperitoneal or intraperitoneal bleeding and carries a very high mortality risk.

Most Likely Diagnosis

Cardiogenic shock complicating acute anterior myocardial infarction

Differential Diagnosis

Hypovolemic shock
Obstructive shock from pulmonary embolism
Cardiac tamponade
Tension pneumothorax
Septic shock
Acute severe mitral regurgitation
Ventricular septal rupture
Right-ventricular infarction
Medication-induced hypotension

Key Investigations

Investigations occur simultaneously with resuscitation:

Serial ECGs
Troponin
Bedside echocardiography
CBC
Electrolytes and creatinine
Liver tests
Lactate
Arterial or venous blood gas
Chest radiograph
Urine-output monitoring
Coronary angiography
Hemodynamic assessment in selected cases

Gold-Standard Assessment

There is no single test that replaces clinical and hemodynamic assessment.
Bedside echocardiography and urgent coronary angiography are central when myocardial
infarction is the suspected cause.

Conventional Treatment

Management may include:

Emergency critical-care and shock-team involvement
Airway and oxygenation support
Urgent coronary reperfusion
Vasopressor support, commonly with norepinephrine when required
Inotropic support in selected patients
Careful volume assessment
Treatment of arrhythmias
Identification and correction of mechanical complications
Temporary mechanical circulatory support in selected cases
Renal and metabolic support

Routine large-volume fluid administration can worsen pulmonary edema in left-ventricular
failure.

Naturopathic Role

There is no role for acute oral botanical, nutritional or physical-medicine treatment during
cardiogenic shock.
After recovery:

Cardiac rehabilitation
Mediterranean-style diet
Smoking cessation
Diabetes and blood-pressure management
Sleep-apnea treatment
Medication adherence
Monitoring for recurrent congestion
Psychosocial and caregiver support

Botanical and Supplement Safety

Do not give oral supplements to an unstable patient.
Avoid unmonitored potassium, magnesium or diuretic products.
Avoid licorice.
Avoid hawthorn during unstable heart failure or shock.
Review supplements affecting platelet function before coronary procedures.
Avoid products interacting with antiplatelets, anticoagulants, vasopressors or
antiarrhythmics.

Complications

● Multiorgan failure

Malignant ventricular arrhythmia
Acute kidney injury
Ischemic hepatitis
Respiratory failure
Limb ischemia
Stroke
Mechanical myocardial rupture
Cardiac arrest
Death

Clinical Pearl

Cold extremities, altered mentation and oliguria indicate systemic hypoperfusion even
before all laboratory results are available.

NPLEX Examination Trap

Do not give routine large fluid boluses to every hypotensive patient. Cardiogenic shock with
pulmonary congestion requires a different approach from hypovolemic shock.

Disease Overview

Cardiogenic shock occurs when cardiac pump failure prevents adequate tissue perfusion. A
self-perpetuating cycle of ischemia, low cardiac output, inflammation, vasoconstriction and
organ injury can rapidly develop without reperfusion and intensive hemodynamic support.

Most Likely Diagnosis

Severe acute asthma exacerbation

Differential Diagnosis

Anaphylaxis
Pulmonary embolism
Pneumothorax
Vocal-cord dysfunction
Foreign-body aspiration
Acute heart failure
Pneumonia
Panic attack

Key Investigations

Treatment should not be delayed for testing.
Appropriate assessment may include:

Serial peak expiratory flow or FEV₁
Continuous oxygen saturation
Arterial or venous blood gas if severe or deteriorating
Chest radiograph when pneumothorax, pneumonia or another diagnosis is suspected
Electrolytes if repeated beta-agonist treatment is required
ECG when arrhythmia or ischemia is a concern

A normal or rising carbon-dioxide level in a severely distressed patient may indicate
respiratory-muscle fatigue rather than improvement.

Conventional Treatment

Emergency management may include:

Controlled supplemental oxygen
Repeated inhaled short-acting beta₂-agonist
Inhaled ipratropium for severe exacerbation
Early systemic corticosteroid
IV magnesium sulfate in selected severe or refractory attacks
Continuous clinical and pulmonary-function reassessment
Ventilatory support if exhaustion, altered consciousness or respiratory failure develops

Long-term asthma management should include an inhaled corticosteroid-containing regimen
rather than reliance on a short-acting bronchodilator alone. The 2026 GINA strategy continues
to emphasize anti-inflammatory inhaled therapy, assessment of exacerbation risk, inhaler
technique and individualized action plans.

Naturopathic Treatment Plan

Natural therapies must not replace acute bronchodilator and corticosteroid treatment.
After stabilization:

Identify environmental and occupational triggers.
Review inhaler technique and adherence.
Establish a written asthma action plan.
Eliminate tobacco and vaping exposure.
Treat allergic rhinitis and reflux when clinically relevant.
Encourage appropriate physical activity when asthma is controlled.
Address obesity and sleep disorders.
Support stress reduction without attributing asthma solely to anxiety.

Botanical and Supplement Safety

Avoid sedating herbs during respiratory distress.
Avoid internal use of essential oils.
Avoid echinacea or other allergenic botanicals in patients with relevant sensitivities.
Avoid stimulant products that intensify tachycardia.
Magnesium supplementation does not substitute for medically supervised IV magnesium
in severe asthma.
● Do not delay epinephrine when anaphylaxis is suspected.

Urgent Referral Criteria

● Inability to speak normally

Oxygen desaturation
Silent or nearly silent chest
Cyanosis
Exhaustion
Confusion or drowsiness
Poor respiratory effort
Peak flow below 50% of predicted or personal best, particularly below 33%
Failure to respond to initial bronchodilator treatment
Previous intensive-care admission or intubation

Clinical Pearl

A quiet chest in a severely breathless patient may indicate minimal airflow and
impending respiratory failure, not improvement.

NPLEX Examination Trap

Do not use a sedating intervention to treat “anxiety” in a hypoxemic patient with severe
bronchospasm.

Disease Overview

Asthma is a variable inflammatory airway disorder characterized by bronchial
hyperresponsiveness and usually reversible airflow limitation. Severe exacerbations cause
bronchoconstriction, mucosal edema and mucus plugging.

Most Likely Diagnosis

Severe acute COPD exacerbation with hypercapnic respiratory failure

Differential Diagnosis

Pneumonia
Pulmonary embolism
Pneumothorax
Acute heart failure
Acute coronary syndrome
Arrhythmia
Pleural effusion
Sedative or opioid toxicity

Key Investigations

Arterial or venous blood gas
Chest radiograph
ECG
CBC
Electrolytes and creatinine
Viral testing when clinically relevant
Sputum culture in severe, recurrent or resistant cases
Troponin and natriuretic peptide when cardiac disease is possible
Pulmonary-embolism assessment when indicated

Conventional Treatment

Management may include:

Controlled supplemental oxygen with repeat blood-gas assessment
Short-acting beta₂-agonist
Short-acting anticholinergic bronchodilator
Short course of systemic corticosteroid
Antibiotics when bacterial infection is sufficiently likely
Noninvasive ventilation for appropriate patients with respiratory acidosis
Intubation and invasive ventilation if noninvasive support fails or is contraindicated
Treatment of precipitating pneumonia, heart failure, arrhythmia or thromboembolism

The 2026 GOLD report remains the current evidence-based strategy for COPD diagnosis,
prevention and management, including acute exacerbations, inhaled therapy, pulmonary
rehabilitation and risk reduction.

Naturopathic Treatment Plan

After stabilization:

Complete smoking-cessation intervention.
Review inhaler technique and adherence.
Refer for pulmonary rehabilitation.
Encourage vaccination according to current recommendations.
Improve protein and calorie intake if underweight.
Pursue gradual weight reduction if obesity impairs breathing.
Reduce occupational and environmental exposures.
Establish an exacerbation action plan.
Evaluate for sleep apnea and long-term oxygen needs.

Botanical and Supplement Safety

Avoid sedating herbs in hypercapnic respiratory disease.
Avoid internal essential oils and concentrated inhaled irritants.
Avoid products marketed as replacements for maintenance inhalers.
Review stimulant-containing decongestants in patients with tachycardia.
Use caution with magnesium-containing products when renal function is impaired.
N-acetylcysteine may be considered only in selected stable patients and does not
replace acute treatment.

Monitoring

● Respiratory rate and work of breathing
● Oxygen saturation

Repeat blood gases
Mental status
Sputum changes
Bronchodilator response
Need for ventilatory support
Frequency of future exacerbations
Weight and nutritional status

Urgent Referral Criteria

Respiratory acidosis
Severe hypoxemia
Drowsiness or confusion
Inability to speak
Hemodynamic instability
Cyanosis
Silent chest
Failure of outpatient therapy
New arrhythmia
Suspected pneumothorax, pneumonia or pulmonary embolism

Clinical Pearl

Oxygen should be given for hypoxemia, but it should be carefully titrated and reassessed
in patients vulnerable to hypercapnic respiratory failure.

NPLEX Examination Trap

Do not withhold oxygen from a hypoxemic COPD patient because of fear of carbon-dioxide
retention. Use controlled oxygen and monitor the response.

Disease Overview

COPD is persistent airflow limitation caused by airway and alveolar abnormalities, usually
following prolonged exposure to tobacco smoke or other inhaled irritants. Exacerbations
accelerate functional decline and increase hospitalization and mortality risk.

Most Likely Diagnosis

Severe community-acquired pneumonia complicated by sepsis

Differential Diagnosis

Aspiration pneumonia
Pulmonary embolism
Acute heart failure
Influenza or other viral pneumonia
Tuberculosis
Lung abscess
Obstructing lung malignancy
Acute respiratory distress syndrome

Key Investigations

Chest radiograph
CBC
Electrolytes and renal and liver function
Serum lactate
Blood cultures when indicated
Sputum Gram stain and culture in selected severe cases
Viral testing
Arterial or venous blood gas
Urinary-antigen testing in selected cases
Pleural ultrasound if an effusion is suspected
CT chest if complications or an obstructing lesion are suspected

Conventional Treatment

Management may include:
● Supplemental oxygen
● IV fluids with careful reassessment
● Empiric antibiotics selected according to disease severity, comorbidities and local
resistance
● Vasopressor support if hypotension persists
● Thrombosis prevention
● Treatment of respiratory failure
● Drainage of empyema or complicated parapneumonic effusion
● Early mobilization and nutritional support when stable
ATS and IDSA maintain formal guidance for the diagnosis and treatment of adult
community-acquired pneumonia. An updated 2025 ATS clinical practice guideline addressed
targeted antibiotic decisions and corticosteroid use in adults with pneumonia.

Naturopathic Treatment Plan

There is no stand-alone naturopathic treatment for severe pneumonia.
During recovery:

Ensure adequate protein and calorie intake.
Encourage hydration appropriate to cardiac and renal status.
Support smoking cessation.
Review vaccination status.
Use gradual breathing and mobility exercises.
Address aspiration risk.
Review oral hygiene.
Monitor for postinfectious fatigue without overlooking persistent disease.

Botanical and Supplement Safety

● Do not delay antibiotics for botanical treatment.
● Avoid sedating cough suppressants in hypoxemia or confusion.
● Avoid combining multiple antiplatelet botanicals when invasive procedures may be
required.
● Avoid concentrated essential-oil ingestion.
● Review herb–antibiotic interactions.
● Probiotics are not substitutes for treatment and require caution in severely
immunocompromised patients.

Complications

Sepsis and septic shock
Respiratory failure
Parapneumonic effusion
Empyema
Lung abscess
Acute kidney injury
Delirium
Acute respiratory distress syndrome

Clinical Pearl

Confusion may be a major presenting feature of pneumonia in an older adult, even when
cough or fever is less prominent.

NPLEX Examination Trap

Do not classify pneumonia as mild solely because it affects only one radiographic lobe.
Physiological instability determines urgency.

Disease Overview

Community-acquired pneumonia is an acute infection of the pulmonary parenchyma acquired
outside a hospital or long-term healthcare exposure. Severity ranges from outpatient disease to
respiratory failure and septic shock.

Most Likely Diagnosis

Traumatic tension pneumothorax causing obstructive shock

Differential Diagnosis

Massive hemothorax
Cardiac tamponade
Pulmonary contusion
Flail chest
Airway obstruction
Massive pulmonary embolism
Acute aortic injury

Key Investigations

No investigation should delay decompression.
After immediate treatment:
● Bedside ultrasound
● Chest radiograph

Arterial blood gas
CBC
Type and crossmatch
Trauma imaging
Continuous cardiac and oxygen monitoring

Conventional Treatment

Immediate pleural decompression
Definitive tube thoracostomy
Supplemental oxygen
Trauma resuscitation
Treatment of associated hemothorax or lung injury
Surgical consultation when air leakage persists or major airway injury is suspected

The British Thoracic Society pleural guideline identifies hemodynamic compromise, significant
hypoxia, bilateral pneumothorax, underlying lung disease and hemopneumothorax as high-risk
features requiring active management.

Naturopathic Role

There is no acute naturopathic treatment.
After recovery:

Smoking cessation
Avoidance of air travel until medically cleared
Avoidance of scuba diving unless specialist criteria are satisfied
Gradual return to physical activity
Recognition of recurrence symptoms
Evaluation for underlying lung disease in secondary pneumothorax

Botanical and Supplement Safety

Do not use inhaled essential oils in acute respiratory distress.
Do not perform chest manipulation.
Do not administer oral products to a patient who may require emergency anesthesia.
Review products that increase bleeding if chest-tube placement or surgery is required.
Avoid smoking and inhaled cannabis because of pulmonary injury and recurrence
concerns.

Urgent Referral Criteria

Every suspected tension pneumothorax is an immediate emergency.
Warning features include:

Hemodynamic compromise
Severe hypoxemia
Unilateral absent breath sounds
Rapid deterioration
Distended neck veins
Tracheal displacement
Altered consciousness
Cardiac arrest

Clinical Pearl

Treat tension pneumothorax clinically; do not wait for radiographic confirmation in an
unstable patient.

NPLEX Examination Trap

Do not confuse tension pneumothorax with a simple pneumothorax that can be observed.
Shock changes the management immediately.

Disease Overview

A tension pneumothorax develops when air enters the pleural cavity but cannot escape. Rising
intrathoracic pressure collapses the lung, shifts mediastinal structures and impairs venous
return to the heart.

Most Likely Diagnosis

Complicated parapneumonic effusion progressing to empyema

Differential Diagnosis

Uncomplicated parapneumonic effusion
Malignant pleural effusion
Tuberculous pleuritis
Hemothorax
Chylothorax
Heart-failure-related transudate
Pulmonary embolism with effusion

Key Investigations

Chest radiograph
Thoracic ultrasound
Contrast-enhanced CT chest
Ultrasound-guided diagnostic thoracentesis
Pleural-fluid pH
Glucose
Protein and LDH
Gram stain and culture
Cytology when malignancy is possible

● Blood cultures
● CBC, inflammatory markers and renal function

Gold-Standard Diagnostic Approach

Diagnosis is based on imaging and pleural-fluid analysis. Frank pus, positive microbiology or
biochemical evidence of a complicated collection supports drainage.

Conventional Treatment

Appropriate IV antimicrobial therapy
Image-guided chest-tube drainage
Intrapleural medication in selected loculated collections
Surgical drainage or decortication if medical drainage fails
Oxygen and sepsis support
Investigation for obstruction, malignancy or aspiration

The BTS pleural guideline covers undiagnosed unilateral effusion, pleural infection, pleural
malignancy and pneumothorax and supports safe, image-guided pleural procedures.

Naturopathic Treatment Plan

Complementary support after source control may include:

Adequate protein and calorie intake
Appropriate hydration
Gradual mobility
Respiratory physiotherapy when prescribed
Smoking cessation
Oral-health and aspiration-risk assessment
Support for antibiotic adherence

Botanical and Supplement Safety

Do not delay drainage for herbal treatment.
Avoid garlic, ginkgo and concentrated omega-3 products before pleural procedures.
Avoid aggressive chest manipulation over an infected collection.
Review all products for antibiotic interactions.
Do not recommend probiotics as substitutes for antimicrobial therapy.

Complications

Sepsis
Bronchopleural fistula
Fibrothorax
Trapped lung
Respiratory failure
Persistent abscess
Malnutrition
Death

Clinical Pearl

A loculated infected pleural collection requires source control; antibiotic penetration
alone may be inadequate.

NPLEX Examination Trap

Do not classify every pneumonia-associated effusion as uncomplicated. Pleural-fluid pH,
glucose, culture and imaging guide the need for drainage.

Disease Overview

A parapneumonic effusion is pleural fluid associated with pneumonia. Progression from sterile
inflammation to bacterial invasion produces a complicated effusion and eventually empyema.

Most Likely Diagnosis

Active cavitary pulmonary tuberculosis

Differential Diagnosis

Lung cancer
Bacterial lung abscess
Nontuberculous mycobacterial infection
Fungal infection
Granulomatosis with polyangiitis
Sarcoidosis
Septic pulmonary emboli

Key Investigations

Sputum nucleic-acid amplification testing
Multiple sputum samples for acid-fast microscopy and culture
Drug-susceptibility testing
Chest radiography or CT
HIV testing with consent
CBC
Liver and renal function
Baseline vision testing when ethambutol is used
Assessment for extrapulmonary involvement
Public-health contact investigation

Gold-Standard or Confirmatory Investigation

Mycobacterial culture confirms the organism and permits full drug-susceptibility testing,
although molecular testing provides faster preliminary identification and resistance information.

Conventional Treatment

Drug-susceptible pulmonary TB is treated with a multidrug regimen. Exact medication
combinations and duration depend on:

Drug susceptibility
Disease location and burden
Treatment response
Comorbidities
Medication tolerance
National and public-health protocols

Directly observed or otherwise supported therapy may be used to promote completion and
prevent resistance. WHO’s 2025 consolidated tuberculosis guidance includes current
recommendations for drug-susceptible and drug-resistant TB treatment, care and patient
support.

Naturopathic Treatment Plan

Complementary care must be coordinated with the TB program:

Support adequate calorie and protein intake.
Assess iron, vitamin D and other deficiencies when clinically indicated.
Avoid alcohol.
Support smoking cessation.
Promote sleep and gradual rehabilitation.
Address medication adherence and social barriers.
Provide mental-health and stigma support.

No natural product should replace multidrug antimicrobial treatment.

Botanical and Supplement Safety

Review all products for hepatotoxicity.
Avoid kava and other potentially hepatotoxic supplements.
Avoid St. John’s wort because it can significantly alter drug metabolism.
Avoid unapproved “immune-stimulating” regimens.
Monitor for additive liver injury with TB medications.
Do not use supplements as substitutes for rifamycin- and isoniazid-based treatment.

Monitoring

● Symptoms and weight
● Sputum conversion
● Medication adherence

Liver function when indicated
Vision and colour discrimination with ethambutol
Neurological symptoms with isoniazid
Drug interactions
Public-health clearance

Urgent Referral Criteria

Significant hemoptysis
Respiratory distress
Hypoxemia
Miliary disease
Neurological symptoms
Suspected TB meningitis
Severe medication toxicity
Pregnancy with active disease
Immunocompromise
Inability to maintain infection precautions

Clinical Pearl

A positive screening test indicates TB infection but does not by itself distinguish latent
infection from active disease.

NPLEX Examination Trap

Do not begin immunosuppressive or immune-modifying treatment for a chronic cough before
excluding active tuberculosis when epidemiological and radiographic risk factors are present.

Disease Overview

Tuberculosis is caused by organisms in the Mycobacterium tuberculosis complex. Pulmonary
cavitary disease can transmit through airborne particles, particularly before effective treatment
reduces infectiousness.

Most Likely Diagnosis

Obstructive sleep apnea

Differential Diagnosis

Central sleep apnea
Insufficient sleep
Narcolepsy
Hypothyroidism
Depression
Sedative medication effect
Obesity hypoventilation syndrome
Periodic limb-movement disorder

Key Investigations

In-laboratory polysomnography
Home sleep-apnea testing in appropriately selected uncomplicated adults
Oxygen saturation and respiratory-event assessment
Serum bicarbonate or blood gas if obesity hypoventilation is suspected
TSH when clinically indicated
Cardiovascular-risk assessment
Medication and substance review

Gold-Standard Investigation

Attended overnight polysomnography is the comprehensive diagnostic standard.

Home testing may be appropriate in selected adults with a high pretest probability and without
major complicating cardiopulmonary or neurological conditions.

Conventional Treatment

Management may include:

Positive airway pressure therapy
Weight reduction
Positional therapy in selected cases
Custom mandibular-advancement device
Treatment of nasal obstruction
Upper-airway surgery in selected patients
Avoidance of alcohol and sedatives near bedtime
Treatment of associated hypertension and metabolic disease

Obstructive sleep apnea involves repeated partial or complete upper-airway collapse during
sleep, producing airflow reduction, oxygen desaturation and sleep fragmentation.

Naturopathic Treatment Plan

Establish sustainable weight-loss strategies.
Encourage regular daytime physical activity.
Maintain consistent sleep timing.
Avoid alcohol near bedtime.
Avoid sedative botanicals unless specifically reviewed.
Treat nasal allergies safely.
Promote side sleeping when positional OSA is demonstrated.
Support consistent CPAP use and equipment care.

Botanical and Supplement Safety

● Sedating herbs may worsen airway obstruction or reduce arousal responses.
● Avoid combining sedative supplements with alcohol, opioids or prescription hypnotics.
● Melatonin may help circadian problems but does not mechanically open an obstructed
airway.
● Avoid stimulant products used to conceal daytime sleepiness.
● Do not recommend nasal essential oils inside CPAP equipment.

Complications

● Motor-vehicle and workplace accidents

Resistant hypertension
Atrial fibrillation
Cardiovascular disease
Stroke
Metabolic dysfunction
Pulmonary hypertension
Cognitive and mood impairment

Urgent Referral Criteria

Falling asleep while driving
Severe daytime somnolence in a safety-sensitive occupation
Suspected obesity hypoventilation
Resting hypoxemia
Heart failure
Significant arrhythmia
Pulmonary hypertension
Opioid-associated sleep-disordered breathing

Clinical Pearl

Snoring alone does not diagnose OSA, but witnessed apneas with excessive daytime
sleepiness require objective assessment.

NPLEX Examination Trap

Do not prescribe a sedating sleep aid for insomnia until sleep apnea has been considered in a
patient with snoring, obesity and daytime somnolence.

Disease Overview

OSA results from repetitive collapse of the upper airway during sleep. Episodes produce
intermittent hypoxemia, carbon-dioxide changes, sympathetic activation and fragmented sleep.

Most Likely Diagnosis

Idiopathic pulmonary fibrosis with usual interstitial pneumonia imaging pattern

Differential Diagnosis

Connective-tissue-disease-associated interstitial lung disease
Chronic hypersensitivity pneumonitis
Asbestosis
Medication-induced pulmonary fibrosis
Sarcoidosis
Fibrotic nonspecific interstitial pneumonia
Combined pulmonary fibrosis and emphysema

Key Investigations

High-resolution CT
Complete pulmonary-function testing
Six-minute walk test
Resting and exertional oxygen assessment
Autoimmune serology guided by history and examination
Detailed occupational, environmental and medication history
Echocardiography when pulmonary hypertension is suspected

● Bronchoscopy or surgical lung biopsy in selected diagnostically uncertain cases

Gold-Standard Diagnostic Approach

Diagnosis should be established through multidisciplinary integration of:

Clinical history
Exposure assessment
High-resolution CT
Serology
Pathology when required

Biopsy may not be necessary when the clinical setting and CT show a confident usual interstitial
pneumonia pattern.

Conventional Treatment

Management may include:

Antifibrotic therapy
Pulmonary rehabilitation
Supplemental oxygen when indicated
Vaccination
Symptom and palliative management
Reflux management when clinically indicated
Lung-transplant referral for suitable patients
Treatment of pulmonary hypertension and comorbidities
Monitoring of pulmonary function and exercise capacity

ATS/ERS/JRS/ALAT guidance addresses the diagnosis and treatment of IPF and progressive
pulmonary fibrosis, emphasizing multidisciplinary diagnosis and evidence-based antifibrotic
management.

Naturopathic Treatment Plan

Adjunctive care may include:

Smoking avoidance
Pulmonary rehabilitation
Adequate protein intake
Prevention of unintended weight loss
Energy-conservation strategies
Breathing techniques for symptom control

● Psychosocial and caregiver support
● Advance-care planning
● Avoidance of occupational inhalational exposures

Botanical and Supplement Safety

No supplement has been shown to reverse established pulmonary fibrosis.
Avoid unregulated oxygen-promoting or “lung detoxification” products.
Avoid internal essential oils.
Review antioxidant supplements for medication interactions.
Avoid products associated with drug-induced lung injury.
Do not delay antifibrotic or transplant assessment for alternative treatment.

Urgent Referral Criteria

Rapidly increasing dyspnea
New resting hypoxemia
Acute diffuse pulmonary infiltrates
Fever or suspected infection
Pulmonary embolism symptoms
Pneumothorax
Syncope or right-heart-failure signs
Rapid decline in pulmonary function

Clinical Pearl

Fine bibasilar crackles, clubbing and unexplained exertional desaturation should prompt
evaluation for fibrotic interstitial lung disease.

NPLEX Examination Trap

Do not prescribe repeated antibiotics for a chronic dry cough when restrictive physiology and
fibrotic imaging are present.

Disease Overview

IPF is a chronic, progressive fibrosing interstitial pneumonia of unknown cause. Repeated
epithelial injury and abnormal repair result in irreversible extracellular-matrix deposition and
declining gas exchange.

Most Likely Diagnosis

Primary bronchogenic carcinoma until proven otherwise

Differential Diagnosis

Tuberculosis
Fungal infection
Lung abscess
Lymphoma
Metastatic cancer
Sarcoidosis
Rounded atelectasis
Benign pulmonary tumour

Key Investigations

Contrast-enhanced CT of the chest and upper abdomen
PET-CT when appropriate for staging
Bronchoscopy with biopsy
Endobronchial ultrasound-guided lymph-node sampling
CT-guided percutaneous biopsy
CBC and metabolic panel
Pulmonary-function testing before potential surgery

● Brain imaging when indicated
● Molecular and biomarker testing after histological diagnosis

Gold-Standard or Confirmatory Investigation

Histopathological confirmation is required to distinguish:

Non-small-cell lung cancer
Small-cell lung cancer
Metastatic disease
Infection
Another pathological process

The biopsy route depends on the lesion’s location, nodal involvement and procedural risk.

Conventional Treatment

Treatment is based on histology, molecular features, stage and functional status and may
include:

Surgical resection
Radiation therapy
Cytotoxic chemotherapy
Targeted therapy
Immunotherapy
Combined-modality treatment
Palliative symptom management
Smoking cessation

Persistent cough, hemoptysis, dyspnea, chest pain and unexplained weight loss are recognized
presentations of lung cancer, particularly in people with significant tobacco exposure.

Naturopathic Treatment Plan

Integrative supportive care may include:

Smoking cessation
Nutritional assessment
Prevention of cancer-associated weight loss
Safe physical activity
Management of sleep and anxiety
Support for treatment adherence
Coordination of symptom care

● Advance-care planning where appropriate

Botanical and Supplement Safety

Review every supplement with the oncology team.
Avoid assuming antioxidants are universally safe during chemotherapy or radiotherapy.
Avoid concentrated products that increase bleeding before biopsy or surgery.
Avoid St. John’s wort because of extensive drug interactions.
Avoid products claiming to cure cancer.
Do not delay biopsy or staging for alternative treatment.

Urgent Referral Criteria

Increasing hemoptysis
Airway obstruction
Superior vena cava syndrome
Stridor
New neurological deficit
Spinal-cord compression symptoms
Hypercalcemia symptoms
Severe hypoxemia
Pericardial tamponade
Pulmonary embolism

Clinical Pearl

A normal examination does not exclude lung cancer; persistent respiratory symptoms
and systemic warning signs require imaging.

NPLEX Examination Trap

Screening recommendations apply to asymptomatic high-risk people. A symptomatic patient
requires diagnostic evaluation, not a screening pathway.

Disease Overview

Lung cancer is a heterogeneous group of malignancies arising from pulmonary or bronchial
tissue. Histology, stage and tumour biomarkers determine treatment and prognosis.

Most Likely Diagnosis

Life-threatening hemoptysis due to bronchiectasis-associated pulmonary bleeding

Differential Diagnosis

Lung cancer
Active tuberculosis
Pulmonary embolism
Aspergilloma
Lung abscess
Necrotizing pneumonia
Arteriovenous malformation
Diffuse alveolar hemorrhage
Anticoagulant-associated bleeding

Key Investigations

Investigations occur simultaneously with stabilization:
● CBC
● Coagulation studies

Type and crossmatch
Renal and liver function
Arterial blood gas
Chest radiograph
CT angiography when stable enough
Bronchoscopy
Sputum microbiology
Vasculitis and autoimmune testing when diffuse alveolar hemorrhage is suspected

Gold-Standard Diagnostic Approach

No single test is best in every unstable patient.
● Bronchoscopy can help secure the airway, localize bleeding and provide temporary
control.
● CT angiography can identify the bleeding source and guide embolization in a
sufficiently stable patient.
● Bronchial-artery angiography permits diagnosis and therapeutic embolization.

Conventional Treatment

Immediate management may include:

Emergency airway protection
High-flow oxygen
Large-bore IV access
Blood-product preparation
Correction of coagulopathy
Positioning with the suspected bleeding lung downward when the source is known
Bronchoscopic isolation and control
Bronchial-artery embolization
Surgical treatment when embolization fails or specific pathology requires resection

Hemoptysis ranges from blood-streaked sputum to unpredictable, life-threatening bleeding that
may require immediate airway establishment and control of the bleeding source.

Naturopathic Role

There is no acute naturopathic treatment for life-threatening hemoptysis.
After stabilization:
● Treat the underlying infection or structural disorder.

Support smoking cessation.
Optimize nutrition.
Participate in prescribed airway-clearance therapy.
Review anticoagulants and supplements.
Support pulmonary rehabilitation when appropriate.
Monitor recurrence.

Botanical and Supplement Safety

Stop and review products that may increase bleeding, including:

Ginkgo
Garlic extracts
Concentrated omega-3 products
High-dose ginger
High-dose turmeric or curcumin
Willow bark
Other salicylate-containing products

No “natural styptic” should delay airway management, embolization or surgery.

Urgent Referral Criteria

Emergency management is required when hemoptysis causes:

Airway compromise
Hypoxemia
Respiratory distress
Hemodynamic instability
Altered consciousness
Rapid ongoing bleeding
Inability to clear blood
Significant anemia
Bleeding while anticoagulated

Clinical Pearl

Most deaths from massive hemoptysis result from asphyxiation rather than
exsanguination.

NPLEX Examination Trap

Do not focus first on measuring the number of millilitres. Airway, oxygenation and physiological
instability determine urgency.

Disease Overview

Hemoptysis is bleeding originating below the vocal cords. Severe bleeding often arises from the
high-pressure bronchial circulation and may rapidly obstruct the central airways.

Differential Diagnosis

● Upper-airway cough syndrome
● Gastroesophageal reflux
● Nonasthmatic eosinophilic bronchitis

ACE-inhibitor-associated cough
Postinfectious cough
Vocal-cord dysfunction
Chronic sinusitis
Environmental or occupational irritant exposure

Key Investigations

Spirometry before and after bronchodilator
Serial peak-flow measurements
Bronchial-provocation testing
Fractional exhaled nitric oxide where available
Allergy assessment when clinically indicated
Chest radiograph for persistent unexplained cough
Medication review
Evaluation for reflux and upper-airway disease

Conventional Treatment

Management generally includes:

An inhaled corticosteroid-containing regimen
A reliever inhaler appropriate to the selected asthma plan
Trigger identification
Inhaler-technique education
Adherence assessment
A written asthma action plan
Follow-up assessment of symptom control and exacerbation risk

The response to treatment supports but does not independently prove the diagnosis. Failure to
improve should prompt reassessment of adherence, technique and alternative diagnoses.

Naturopathic Treatment Plan

Eliminate tobacco, vaping and workplace irritants.
Identify allergen-related symptom patterns.
Support regular sleep and appropriate physical activity.
Treat clinically significant allergic rhinitis.
Encourage weight management when relevant.
Use breathing retraining as an adjunct when dysfunctional breathing coexists.
Avoid assuming that emotional stress is the sole cause of cough.

Botanical and Supplement Safety

Do not replace inhaled corticosteroid treatment with herbs.
Avoid internal ingestion of essential oils.
Avoid stimulant-containing products that worsen palpitations.
Echinacea and other botanicals may cause allergic reactions in susceptible patients.
Sedating botanicals may impair recognition of respiratory deterioration.
Magnesium supplementation does not replace standard asthma treatment.

Monitoring

Nighttime cough
Exercise limitation
Reliever use
Peak-flow variability
Exacerbations
Inhaler technique
Treatment adherence
Development of wheezing, dyspnea or hypoxemia

Urgent Referral Criteria

Difficulty speaking
Oxygen desaturation
Severe breathlessness
Silent chest
Cyanosis
Exhaustion
Altered mental status
Failure to respond to rescue treatment
Significant hemoptysis
Suspected foreign-body aspiration or pulmonary embolism

Clinical Pearl

Asthma may present with cough alone; normal resting spirometry does not exclude
variable airway disease.

NPLEX Examination Trap

Do not diagnose asthma solely from symptoms. Seek objective evidence of variable expiratory
airflow limitation or airway hyperresponsiveness whenever feasible.

Disease Overview

Cough-variant asthma is an asthma phenotype in which chronic cough is the principal symptom.
Airway inflammation and hyperresponsiveness are present even when obvious wheezing and
baseline airflow obstruction are absent.

Most Likely Diagnosis

Bronchiectasis with an acute infective exacerbation

Differential Diagnosis

COPD exacerbation
Cystic fibrosis
Primary ciliary dyskinesia
Immunodeficiency

Allergic bronchopulmonary aspergillosis
Nontuberculous mycobacterial infection
Recurrent aspiration
Active tuberculosis
Obstructing endobronchial lesion

Key Investigations

Sputum Gram stain and bacterial culture
Mycobacterial cultures when indicated
CBC and inflammatory markers
Chest radiograph for suspected pneumonia
Oxygen assessment
Pulmonary-function testing after stabilization
Quantitative immunoglobulins
Testing for allergic bronchopulmonary aspergillosis
Evaluation for cystic fibrosis or ciliary dysfunction when clinically appropriate
CT review for extent and progression

Gold-Standard Investigation

High-resolution CT of the chest confirms abnormal, permanent bronchial dilation and defines
disease distribution.

Conventional Treatment

Culture-guided antibiotic treatment
Airway-clearance physiotherapy
Adequate hydration when medically appropriate
Bronchodilator treatment when reversible obstruction is present
Treatment of underlying causes
Long-term macrolide or inhaled antibiotic therapy in selected frequently exacerbating
patients
● Vaccination
● Pulmonary rehabilitation
● Specialist management of recurrent hemoptysis
Treatment goals are to reduce symptoms and exacerbations, improve quality of life and prevent
progression.

Naturopathic Treatment Plan

Support adequate protein and calorie intake.
Encourage hydration compatible with cardiac and renal function.
Reinforce prescribed airway-clearance techniques.
Promote smoking and vaping avoidance.
Address reflux and aspiration risk.
Encourage regular physical activity after stabilization.
Support sleep and energy conservation.
Assist with adherence to antimicrobial and inhaled therapies.

Botanical and Supplement Safety

Avoid strong sedating cough suppressants when secretions are heavy.
Do not inhale irritating essential oils.
Avoid replacing antibiotics with garlic, oregano oil or colloidal silver.
Review garlic, ginkgo and high-dose omega-3 supplements in patients with hemoptysis.
Avoid unregulated nebulized products.
N-acetylcysteine may be considered only when appropriate and does not replace airway
clearance or antibiotics.

Monitoring

Sputum volume and colour
Exacerbation frequency
Hemoptysis
Oxygen saturation
Weight and nutritional status
Pulmonary function
Microbiology
Antimicrobial adverse effects
Hearing and ECG where prolonged macrolide therapy is used

Urgent Referral Criteria

Significant or increasing hemoptysis
Severe hypoxemia
Respiratory distress
Sepsis
New focal consolidation
Confusion
Hypotension
Failure of outpatient antibiotics
Suspected pulmonary embolism or pneumothorax

Clinical Pearl

In bronchiectasis, sputum microbiology from previous exacerbations helps guide initial
antimicrobial selection.

NPLEX Examination Trap

Do not suppress a productive cough indiscriminately. Retained infected mucus can worsen
obstruction and infection.

Disease Overview

Bronchiectasis is permanent bronchial dilation associated with impaired mucus clearance,
chronic airway inflammation and recurrent infection. Repeated infection and inflammation create
a self-perpetuating cycle of airway damage.

Differential Diagnosis

Tuberculosis
Fungal infection
Lymphoma
Berylliosis
Hypersensitivity pneumonitis
Granulomatosis with polyangiitis
Common variable immunodeficiency
Drug-induced granulomatous disease

Key Investigations

Chest radiograph
High-resolution CT
Pulmonary-function tests
CBC
Calcium and renal function
Liver enzymes
ECG
Eye examination
Tissue biopsy when needed
Microbiological testing to exclude infection
Occupational and environmental exposure history

Gold-Standard Diagnostic Approach

There is no single blood test that confirms sarcoidosis. Tissue sampling demonstrating
non-necrotizing granulomas, combined with compatible clinical findings and exclusion of
alternative causes, establishes the diagnosis in most uncertain cases.

Conventional Treatment

Some patients with mild or self-limited disease require observation rather than medication.
Treatment is considered when there is:

Progressive pulmonary impairment
Significant symptoms
Ocular disease
Neurological disease
Cardiac involvement
Clinically important hypercalcemia
Organ-threatening extrapulmonary disease

Systemic corticosteroids are commonly used first-line for clinically important pulmonary
sarcoidosis, while steroid-sparing immunomodulators may be considered for persistent disease
or corticosteroid toxicity.

Naturopathic Treatment Plan

Encourage smoking avoidance.
Maintain regular activity within respiratory tolerance.
Support adequate nutrition.
Monitor calcium and vitamin D decisions carefully.
Address fatigue, sleep and mood.
Coordinate all anti-inflammatory supplements with the specialist.
Encourage regular ophthalmic and cardiac screening where indicated.

Botanical and Supplement Safety

● Avoid unsupervised vitamin D or calcium supplementation because sarcoidosis can
increase active vitamin D production and cause hypercalcemia.
● Avoid “immune-stimulating” botanicals in active immune-mediated disease.
● Review products for interactions with corticosteroids, methotrexate or other
immunosuppressants.
● Avoid hepatotoxic supplements when liver involvement or methotrexate use is present.
● Do not delay evaluation for cardiac or neurological sarcoidosis.

Monitoring

Respiratory symptoms
Pulmonary-function trends
Chest imaging
Calcium and renal function
Eye symptoms
Palpitations or syncope
Neurological symptoms
Medication adverse effects
Extrapulmonary organ involvement

Urgent Referral Criteria

Syncope
Sustained palpitations
Conduction block
Ventricular arrhythmia

New neurological deficit
Visual loss
Severe hypercalcemia
Progressive respiratory failure
Pulmonary hypertension
Suspected cardiac sarcoidosis

Clinical Pearl

Sarcoidosis can increase active vitamin D and calcium levels; routine high-dose vitamin
D supplementation may be unsafe.

NPLEX Examination Trap

Do not diagnose sarcoidosis from an elevated angiotensin-converting-enzyme level alone. It is
neither sufficiently sensitive nor specific.

Disease Overview

Sarcoidosis is a multisystem granulomatous disease that most commonly affects the lungs and
intrathoracic lymph nodes. The clinical course ranges from spontaneous remission to
progressive pulmonary fibrosis or organ-threatening extrapulmonary disease.

Most Likely Diagnosis

Bird-related hypersensitivity pneumonitis

Differential Diagnosis

Idiopathic pulmonary fibrosis
Sarcoidosis
Occupational asthma
Nontuberculous mycobacterial disease
Fungal infection
Connective-tissue-disease-associated interstitial lung disease
Medication-induced pneumonitis
Organic-dust toxic syndrome

Key Investigations

Detailed occupational and environmental history
High-resolution CT
Complete pulmonary-function tests
Resting and exertional oxygen assessment
Serum antigen-specific IgG as an exposure-supporting test
Bronchoalveolar lavage lymphocyte analysis
Autoimmune testing when indicated
Lung biopsy in unresolved cases
Home or workplace environmental assessment

Gold-Standard Diagnostic Approach

No single investigation is independently diagnostic. The diagnosis is established by combining:

A credible exposure
Compatible imaging
Physiological impairment
Bronchoalveolar-lavage or pathological findings
Exclusion of competing diagnoses

Conventional Treatment

● Complete antigen avoidance
● Occupational and environmental intervention
● Supplemental oxygen when indicated

Pulmonary rehabilitation
Corticosteroid therapy in selected symptomatic inflammatory disease
Immunomodulatory or antifibrotic strategies in selected progressive fibrotic disease
Lung-transplant assessment in advanced cases

Naturopathic Treatment Plan

Remove birds, contaminated bedding or other identified sources.
Avoid attempting partial exposure reduction when complete removal is feasible.
Use appropriate respiratory protection during unavoidable temporary remediation.
Avoid smoking and vaping.
Support adequate nutrition and physical conditioning.
Address emotional and practical barriers to antigen removal.
Coordinate rehabilitation and oxygen needs.

Botanical and Supplement Safety

Do not substitute anti-inflammatory herbs for exposure removal.
Avoid inhaled essential oils and aerosolized supplements.
Avoid unreviewed immune-stimulating botanicals.
Review supplements for corticosteroid or immunosuppressant interactions.
Do not use antioxidant therapy as justification for remaining exposed.

Monitoring

Symptoms after exposure removal
Oxygen saturation
Pulmonary function
Exercise capacity
High-resolution CT when clinically indicated
Evidence of fibrosis
Treatment adverse effects
Pulmonary-hypertension symptoms

Urgent Referral Criteria

Rapidly worsening dyspnea
New resting hypoxemia
Severe respiratory distress
Acute diffuse infiltrates
Syncope
Signs of pulmonary hypertension

● Pneumothorax
● Progressive respiratory failure

Clinical Pearl

A symptom pattern that improves away from home or work is a major clue to
environmentally triggered lung disease.

NPLEX Examination Trap

Do not rely on serum precipitating antibodies alone. They show exposure and sensitization but
do not prove clinically active hypersensitivity pneumonitis.

Disease Overview

Hypersensitivity pneumonitis is an immune-mediated interstitial and small-airway disease
caused by repeated inhalation of an antigen in a susceptible person. Persistent exposure may
progress from inflammation to irreversible fibrosis.

Most Likely Diagnosis

Acute respiratory distress syndrome secondary to pneumonia and sepsis

Differential Diagnosis

Cardiogenic pulmonary edema
Diffuse alveolar hemorrhage
Acute eosinophilic pneumonia
Severe viral pneumonitis
Acute interstitial pneumonia
Transfusion-related acute lung injury
Pneumocystis pneumonia
Organizing pneumonia

Key Investigations

Serial blood gases
Chest radiography
Lung and cardiac ultrasound
Echocardiography
CBC and metabolic panel
Blood and respiratory cultures
Viral testing
Lactate
Bronchoscopy in selected cases
Evaluation for pulmonary embolism or alveolar hemorrhage when indicated

Conventional Treatment

Treatment of sepsis or the initiating cause
Lung-protective mechanical ventilation
Appropriate positive end-expiratory pressure
Prone positioning for selected moderate-to-severe ARDS
Conservative fluid strategy after initial shock resuscitation
Neuromuscular blockade in selected cases
Venous-thromboembolism and stress-ulcer prevention
Extracorporeal support in carefully selected refractory cases

ATS/ESICM/SCCM guidance supports low-tidal-volume ventilation and recommends prone
positioning for severe ARDS as part of an evidence-based ventilatory strategy.

Naturopathic Role

There is no acute naturopathic treatment for ARDS.
During recovery:

Nutritional rehabilitation
Progressive physical therapy
Pulmonary rehabilitation
Cognitive and psychological support
Sleep restoration
Smoking avoidance
Evaluation of post-intensive-care syndrome
Coordination of long-term oxygen needs

Botanical and Supplement Safety

● Do not administer oral supplements to an unstable or intubated patient unless directed
through the critical-care nutrition plan.
● Avoid herbal diuretics.
● Avoid products that increase bleeding when invasive procedures are needed.
● Avoid immune-stimulating products in uncontrolled inflammatory disease.
● Review all supplements for hepatic, renal and medication interactions.

Complications

Ventilator-associated pneumonia
Barotrauma
Pneumothorax
Thromboembolism
Critical-illness neuropathy and myopathy
Delirium
Pulmonary fibrosis
Multiorgan failure
Death

Clinical Pearl

ARDS is noncardiogenic inflammatory pulmonary edema; excluding major cardiac failure
is part of the diagnosis.

NPLEX Examination Trap

Do not treat all bilateral pulmonary opacities as fluid-overload heart failure. The clinical context
and cardiac assessment determine the mechanism.

Disease Overview

ARDS involves diffuse injury to the alveolar-capillary barrier, causing protein-rich pulmonary
edema, reduced lung compliance, impaired gas exchange and severe hypoxemia.

Most Likely Diagnosis

GERD with an alarm presentation requiring exclusion of esophageal stricture or
malignancy

Differential Diagnosis

Peptic esophageal stricture
Esophageal adenocarcinoma
Barrett esophagus
Eosinophilic esophagitis
Achalasia
Esophageal motility disorder
Pill esophagitis
Gastric-cardia malignancy

Key Investigations

Upper endoscopy with biopsy
CBC and iron studies
Barium esophagram in selected structural or motility presentations
Esophageal manometry if a motility disorder is suspected
Ambulatory reflux monitoring when diagnosis remains uncertain
Testing for gastrointestinal blood loss when appropriate

Gold-Standard Investigation

Upper endoscopy is the preferred initial test when alarm features are present.
Ambulatory reflux monitoring provides objective evidence of pathological reflux when endoscopy
is nondiagnostic and diagnostic confirmation is still needed.

Conventional Treatment

Depending on findings:

Proton-pump inhibitor therapy
Treatment of erosive esophagitis
Endoscopic dilation of a benign stricture
Barrett surveillance or treatment
Surgical or endoscopic reflux intervention in selected patients
Cancer staging and multidisciplinary treatment if malignancy is identified

For typical GERD without alarm symptoms, ACG guidance supports an empiric
proton-pump-inhibitor trial, but dysphagia, bleeding, anemia or weight loss warrants endoscopic
assessment.

Naturopathic Treatment Plan

After urgent pathology has been excluded:

Avoid meals within two to three hours of bedtime.
Elevate the head of the bed for nocturnal symptoms.
Pursue weight reduction when overweight.
Stop smoking.
Identify individual food triggers rather than imposing unnecessary broad restrictions.
Use smaller meals when large meals provoke symptoms.
Limit alcohol when it worsens reflux.

Botanical and Supplement Safety

Peppermint may worsen reflux.
Avoid irritating concentrated essential oils.
Review licorice products for glycyrrhizin-related hypertension and hypokalemia.
Deglycyrrhizinated licorice does not replace endoscopy or acid-suppressive treatment.
Fibre and supplements may interfere with medication absorption.
Avoid delaying dysphagia evaluation for natural treatment.

Urgent Referral Criteria

Progressive dysphagia
Food impaction
Hematemesis
Melena
Anemia
Unintentional weight loss
Persistent vomiting
Severe chest pain
Suspected perforation
Aspiration symptoms

Clinical Pearl

Dysphagia is an alarm symptom; it should not be managed as uncomplicated reflux
without investigation.

NPLEX Examination Trap

Do not prescribe peppermint for a patient whose dominant problem is reflux. Peppermint may
worsen lower-esophageal-sphincter relaxation.

Disease Overview

GERD occurs when gastric contents reflux into the esophagus and cause troublesome
symptoms or complications. Chronic disease may lead to erosive esophagitis, stricture and
Barrett esophagus.

Most Likely Diagnosis

H. pylori-associated duodenal peptic ulcer disease

Differential Diagnosis

NSAID-associated ulcer
Functional dyspepsia
Gastric malignancy
GERD
Pancreatic disease
Biliary disease
Crohn disease
Zollinger–Ellison syndrome

Key Investigations

● Urea breath test

Stool antigen test
Endoscopic biopsy testing
CBC
Iron studies when anemia is present
Upper endoscopy for alarm symptoms or appropriate age/risk
Review of NSAIDs, aspirin, anticoagulants and smoking

Gold-Standard Diagnostic Approach

No single test is required in every patient.
● Urea breath testing and stool antigen testing detect active infection noninvasively.
● Biopsy-based testing is used during endoscopy.
● Serology may remain positive after eradication and is not suitable for confirming cure.

Conventional Treatment

A commonly recommended treatment-naïve regimen is 14-day optimized bismuth quadruple
therapy consisting of:

A proton-pump inhibitor
Bismuth
Tetracycline
Metronidazole

Alternative regimens depend on allergies, previous antibiotic exposure, regional resistance and
susceptibility testing. All treated patients should undergo a test of cure using an appropriate
active-infection test after a suitable post-treatment interval and appropriate withholding of
interfering acid-suppressive medication.

Naturopathic Treatment Plan

Stop unnecessary NSAIDs.
Stop smoking.
Limit alcohol if it worsens symptoms.
Maintain regular, nutritionally adequate meals.
Avoid individually aggravating foods.
Support adherence to the complete antibiotic course.
Address medication-related nausea without discontinuing treatment prematurely.
Reassess persistent symptoms after eradication.

Botanical and Supplement Safety

● Do not substitute mastic gum, berberine, garlic or probiotics for eradication therapy.
● Bismuth-containing supplements can darken stool and tongue.
● Avoid combining herbal antimicrobials with prescription therapy without interaction
review.
● Licorice containing glycyrrhizin may cause hypertension and hypokalemia.
● Probiotics may reduce some treatment-associated gastrointestinal symptoms but are not
curative monotherapy.

Monitoring

Medication completion
Adverse effects
Test of eradication
Recurrent pain
Bleeding symptoms
Anemia
NSAID exposure
Persistent vomiting or weight loss

Urgent Referral Criteria

Hematemesis
Melena
Syncope
Hypotension
Sudden severe generalized abdominal pain
Rigid abdomen
Persistent vomiting
Progressive weight loss
Severe anemia

Clinical Pearl

Treating symptoms is not enough—eradication must be confirmed after H. pylori therapy.

NPLEX Examination Trap

Do not use serology to confirm eradication because antibodies can remain positive long after
successful treatment.

Disease Overview

Peptic ulcers are mucosal defects in the stomach or duodenum. The most important causes are
H. pylori infection and NSAID exposure. Complications include bleeding, perforation,
penetration and gastric-outlet obstruction.

Most Likely Diagnosis

Acute upper gastrointestinal bleeding, likely NSAID-associated peptic-ulcer hemorrhage
complicated by anticoagulation

Differential Diagnosis

Esophageal or gastric varices
Erosive gastritis
Mallory–Weiss tear
Esophagitis

Gastric malignancy
Dieulafoy lesion
Aortoenteric fistula
Hemobilia

Key Investigations

CBC
Type and crossmatch
Electrolytes and renal function
Liver tests
Coagulation studies
Lactate
Serial hemoglobin
ECG and troponin in high-risk patients
Urgent upper endoscopy
CT angiography or catheter angiography when endoscopy fails or bleeding is too brisk

Gold-Standard Investigation

Upper endoscopy is the principal diagnostic and therapeutic procedure after initial stabilization.

Conventional Treatment

Airway protection when aspiration risk is high
IV access and resuscitation
Restrictive, individualized transfusion strategy
IV proton-pump inhibitor treatment
Endoscopic hemostasis
Management or reversal of anticoagulation when clinically indicated
Discontinuation of unnecessary NSAIDs
Testing and treatment for H. pylori
Interventional-radiology embolization or surgery for uncontrolled bleeding

Acute gastrointestinal bleeding in anticoagulated patients requires balancing hemorrhage
control with thromboembolic risk; specific decisions depend on bleeding severity, anticoagulant
type and clinical indication.

Naturopathic Role

There is no acute naturopathic treatment.

After stabilization:

Avoid NSAIDs unless specifically required.
Stop smoking.
Limit alcohol.
Support iron and nutrient repletion when prescribed.
Reinforce acid-suppressive and eradication treatment adherence.
Review all supplements that affect coagulation.

Botanical and Supplement Safety

Potential bleeding-promoting products include:

Garlic
Ginkgo
High-dose ginger
Concentrated turmeric or curcumin
Willow bark
High-dose omega-3 products

These should be reviewed urgently, particularly with antiplatelets or anticoagulants. Oral
supplements should not be given during active major bleeding.

Urgent Referral Criteria

Hematemesis
Melena with weakness or dizziness
Hypotension
Tachycardia
Syncope
Confusion
Chest pain
Ongoing anticoagulant use
Severe anemia
Recurrent bleeding after endoscopic treatment

Clinical Pearl

In acute hemorrhage, the initial hemoglobin may not reflect the full blood loss; vital signs
and perfusion determine urgency.

NPLEX Examination Trap

Do not delay resuscitation while trying to identify the exact bleeding lesion.

Disease Overview

Upper gastrointestinal bleeding originates proximal to the ligament of Treitz. Peptic-ulcer
disease is a major cause, but varices, mucosal erosions, vascular lesions and malignancy must
also be considered.

Differential Diagnosis

Celiac disease
Inflammatory bowel disease
Microscopic colitis
Lactose intolerance
Bile-acid diarrhea
Chronic infection
Endometriosis
Hyperthyroidism
Medication-induced diarrhea

Key Investigations

Testing should be selective:

CBC
Celiac serology
CRP
Fecal calprotectin
Stool studies when infection risk is present
Thyroid testing when indicated
Colonoscopy for alarm features, screening indications or diagnostic uncertainty

Conventional Treatment

Management may include:

Education and reassurance
Soluble fibre
A limited low-FODMAP dietary trial with structured reintroduction
Antidiarrheal medication
Antispasmodic therapy
Gut-directed psychotherapy
Tricyclic antidepressant in selected patients
IBS-D-specific medication according to severity and contraindications

ACG guidance supports a limited trial of a low-FODMAP diet and gut-directed psychotherapy for
global IBS symptoms.

Naturopathic Treatment Plan

Use a food and symptom diary.
Trial soluble fibre such as psyllium gradually.
Avoid excessive insoluble bran if it worsens symptoms.
Use a time-limited low-FODMAP program under dietary supervision.
Reintroduce foods to prevent unnecessary long-term restriction.
Encourage regular meals, sleep and physical activity.
Address stress through cognitive-behavioural or gut-directed approaches.

Botanical and Supplement Safety

● Enteric-coated peppermint oil may help some patients but can worsen GERD.
● Avoid excessive stimulant laxatives.
● Avoid prolonged broad antimicrobial herbal regimens without indication.

● Probiotics have variable strain-specific evidence and should not be presented as
universally effective.
● Review supplements for hidden magnesium, sugar alcohols or caffeine that may worsen
diarrhea.
● Avoid highly restrictive diets that create nutritional deficiency.

Monitoring

Abdominal-pain frequency
Stool form and urgency
Dietary adequacy
Weight
Psychosocial impact
New bleeding
Nocturnal symptoms
Treatment adverse effects

Urgent Referral Criteria

Gastrointestinal bleeding
Unintentional weight loss
Iron-deficiency anemia
Fever
Nocturnal diarrhea
Persistent vomiting
Palpable mass
Family history of colorectal cancer or inflammatory bowel disease
New symptoms at an older age

Clinical Pearl

IBS is a disorder of gut–brain interaction with genuine symptoms; it is not simply a
diagnosis of anxiety.

NPLEX Examination Trap

Do not order repeated imaging and colonoscopy in a young patient who meets symptom criteria
and has no alarm features.

Disease Overview

IBS is characterized by recurrent abdominal pain associated with defecation or altered bowel
habits without structural disease explaining the symptoms. Visceral hypersensitivity, motility
changes, microbiome factors and gut–brain interactions contribute.

Differential Diagnosis

Ulcerative colitis
Intestinal tuberculosis
Yersinia infection
Celiac disease
Behçet disease
NSAID enteropathy
Ischemic bowel disease
Small-bowel lymphoma

Key Investigations

CBC
CRP and ESR
Albumin and metabolic panel
Iron, vitamin B12, folate and vitamin D assessment
Fecal calprotectin
Stool cultures and C. difficile testing
Ileocolonoscopy with biopsy
MR or CT enterography
Pelvic MRI for perianal disease
Screening for tuberculosis and hepatitis before selected immunosuppressive treatment

Gold-Standard Diagnostic Approach

Diagnosis is established through integration of:

Clinical presentation
Endoscopic findings
Histopathology
Cross-sectional imaging
Exclusion of infection and other inflammatory disorders

Conventional Treatment

Treatment depends on location, severity, complications and prognostic risk and may include:

Corticosteroids for short-term induction in selected active disease
Immunomodulators
Biologic therapy
Targeted small-molecule therapy
Nutritional treatment in selected situations
Antibiotics for specific septic or perianal complications
Surgery for obstruction, perforation, abscess, fistula, dysplasia or refractory disease

Corticosteroids are not appropriate maintenance therapy. Current ACG guidance emphasizes
effective steroid-sparing maintenance and earlier advanced treatment for moderate-to-severe or
high-risk disease.

Naturopathic Treatment Plan

Adjunctive care should be coordinated with gastroenterology:

Correct iron, B12, folate, vitamin D and other deficiencies.
Provide adequate protein and calories.
Avoid unnecessary restrictive diets.
Use lower-residue intake temporarily if a symptomatic stricture is present.
Stop smoking.
Support medication adherence.
Address fatigue, sleep and mental health.
Refer to a dietitian familiar with inflammatory bowel disease.

Botanical and Supplement Safety

Avoid immune-stimulating botanicals in active autoimmune inflammatory disease.
Avoid NSAID-like herbs and willow bark when bleeding risk exists.
Avoid stimulant laxatives.
Curcumin evidence is stronger in ulcerative colitis than Crohn disease and should not
replace standard therapy.
● Review all supplements for interactions with immunosuppressants.
● Avoid live probiotics in severely immunocompromised or critically ill patients without
specialist review.
● Do not treat obstruction or abscess with diet and herbs alone.

Monitoring

Stool frequency and bleeding
Abdominal pain
Weight and growth where relevant
CBC and inflammatory markers
Albumin
Nutritional deficiencies
Fecal calprotectin
Endoscopic or imaging evidence of healing
Medication toxicity
Infection risk
Bone health

Urgent Referral Criteria

Severe localized abdominal pain
Guarding or rebound
Persistent vomiting
Abdominal distension
High fever

Perianal abscess
Gastrointestinal bleeding
Severe dehydration
Suspected obstruction, perforation or toxic megacolon
Immunosuppressive-treatment infection

Clinical Pearl

Normal symptoms do not always equal controlled Crohn disease; objective inflammatory
monitoring is important.

NPLEX Examination Trap

Do not diagnose IBS when anemia, weight loss, hypoalbuminemia, elevated calprotectin or
endoscopic inflammation is present.

Disease Overview

Crohn disease is a chronic relapsing inflammatory disorder that may involve any gastrointestinal
segment. Transmural inflammation distinguishes it from superficial mucosal disorders and
explains its risks of fistula, abscess, stricture and penetrating disease.

Most Likely Diagnosis

Acute severe ulcerative colitis complicated by toxic megacolon

Differential Diagnosis

Fulminant Clostridioides difficile colitis
Infectious colitis
Crohn colitis
Ischemic colitis
Cytomegalovirus colitis
Mechanical large-bowel obstruction
Colonic pseudo-obstruction

Key Investigations

CBC
Electrolytes, magnesium and renal function
CRP and albumin
Liver tests
Blood cultures when septic
Stool culture and C. difficile testing
Serial abdominal radiographs
Limited flexible sigmoidoscopy with cautious biopsy when appropriate
CT abdomen if perforation, abscess or another complication is suspected

Gold-Standard Diagnostic Approach

Diagnosis is clinical and radiographic. Toxic megacolon requires nonobstructive colonic dilation
accompanied by systemic toxicity in the setting of severe colitis.

Conventional Treatment

Emergency hospitalization
IV fluids and electrolyte replacement
IV corticosteroid
Pharmacological thrombosis prophylaxis unless contraindicated
Avoidance of opioids, anticholinergics and antidiarrheal medications
Treatment of confirmed infection
Nutritional support
Daily assessment with gastroenterology and colorectal surgery
Rescue infliximab or cyclosporine in selected steroid-refractory disease
Urgent colectomy for perforation, uncontrolled bleeding, worsening toxic megacolon or
failed medical treatment

The current treatment goal in UC is durable, steroid-free remission with objective control of
inflammation.

Naturopathic Treatment Plan

No naturopathic treatment is appropriate as primary therapy during toxic megacolon.
After recovery:

Correct iron, folate, vitamin D and other deficiencies.
Maintain adequate protein and calorie intake.
Avoid unnecessarily restrictive diets.
Support medication adherence.
Encourage smoking avoidance.
Address sleep, stress and mental-health needs.
Coordinate dietary interventions with gastroenterology and an IBD-experienced dietitian.

Botanical and Supplement Safety

Avoid stimulant laxatives.
Avoid antidiarrheal herbs during severe colitis.
Avoid aloe latex.
Avoid high-dose magnesium products.
Avoid immune-stimulating botanicals during uncontrolled inflammatory disease.
Curcumin may have a limited adjunctive role in selected mild-to-moderate UC but does
not treat acute severe colitis.

● Review all supplements for interactions with corticosteroids, biologics and
immunomodulators.

Monitoring

Stool frequency and bleeding
Abdominal circumference and tenderness
Vital signs
Hemoglobin
CRP
Electrolytes
Albumin
Colonic diameter
Signs of perforation or sepsis
Response to IV corticosteroid

Urgent Surgical Indications

Perforation
Peritonitis
Uncontrolled hemorrhage
Progressive colonic dilation
Rising lactate
Worsening shock
Failure of medical rescue treatment
Multiorgan dysfunction

Clinical Pearl

Toxic megacolon is defined by colonic dilation plus systemic toxicity—not by abdominal
distension alone.

NPLEX Examination Trap

Do not give loperamide, opioids or anticholinergic agents to a patient with severe inflammatory
colitis and colonic dilation.

Disease Overview

Ulcerative colitis causes continuous mucosal inflammation beginning in the rectum and
extending proximally through part or all of the colon. Severe inflammation may impair colonic
muscular tone and produce toxic dilation.

Most Likely Diagnosis

Celiac disease with iron-deficiency anemia and probable dermatitis herpetiformis

Differential Diagnosis

Crohn disease
Giardiasis
Common variable immunodeficiency
Tropical sprue
Small-intestinal bacterial overgrowth
Autoimmune enteropathy
Medication-induced enteropathy
Non-celiac gluten sensitivity

Key Investigations

Tissue-transglutaminase IgA
Total serum IgA
IgG-based testing if IgA deficient
Upper endoscopy with multiple duodenal biopsies
CBC
Iron studies
Folate and vitamin B12
Calcium, phosphate and vitamin D
Liver enzymes
TSH when autoimmune thyroid disease is suspected
Bone-density assessment when indicated

Gold-Standard Diagnostic Approach

For most adults, diagnosis is based on compatible serology plus characteristic duodenal
histology while consuming gluten.
HLA-DQ2/DQ8 testing can help exclude celiac disease in selected uncertain cases because
absence of both makes the diagnosis very unlikely.

Conventional Treatment

Lifelong strict gluten-free diet
Referral to a dietitian experienced in celiac disease
Correction of iron and other nutrient deficiencies
Assessment of bone health
Screening for associated autoimmune conditions when indicated
Repeat serology to assess adherence and response
Repeat biopsy in selected patients with persistent symptoms
Evaluation for refractory disease when appropriate

A strict gluten-free diet is the central treatment; medications are not usually required unless
disease is refractory or another complication is present.

Naturopathic Treatment Plan

Remove wheat, barley and rye.
Use certified gluten-free oats when tolerated.
Prevent cross-contamination in kitchens and restaurants.
Replace nutrients using naturally gluten-free whole foods.

● Correct iron, folate, B12, vitamin D, calcium and zinc deficiencies based on testing.
● Avoid an overly processed gluten-free diet.
● Assess lactose intolerance during early mucosal healing.

Botanical and Supplement Safety

Verify that supplements are certified gluten-free.
Review herbal capsules, excipients and flavouring agents for gluten contamination.
Do not treat celiac disease with digestive enzymes alone.
“Gluten-digesting” supplements do not make intentional gluten exposure safe.
Avoid unnecessary immune-stimulating products.
Iron supplements should be dosed according to deficiency and tolerance.

Monitoring

Weight
Stool pattern
Hemoglobin and ferritin
Celiac serology
Nutritional deficiencies
Bone health
Diet adherence
Persistent rash
Symptoms suggesting lymphoma or refractory disease

Urgent Referral Criteria

Severe dehydration
Major weight loss
Profound malnutrition
Gastrointestinal bleeding
Severe abdominal pain
Persistent vomiting
Suspected intestinal obstruction
Neurological deterioration
Failure to respond to a verified gluten-free diet

Clinical Pearl

Testing for celiac disease should generally be completed while the patient is still eating
gluten.

NPLEX Examination Trap

Do not advise a gluten-free trial before completing diagnostic testing in a stable patient with
suspected celiac disease.

Disease Overview

Celiac disease is an immune-mediated enteropathy triggered by gluten in genetically
susceptible people. Villous injury causes nutrient malabsorption and may present with
gastrointestinal, hematologic, neurological, dermatologic or skeletal manifestations.

Most Likely Diagnosis

Acute appendicitis

Differential Diagnosis

Mesenteric adenitis
Gastroenteritis
Crohn ileitis
Meckel diverticulitis

Renal colic
Pyelonephritis
Ectopic pregnancy
Ovarian torsion
Pelvic inflammatory disease
Testicular torsion

Key Investigations

CBC
CRP
Electrolytes and renal function
Urinalysis
Pregnancy test when relevant
Ultrasound
CT abdomen and pelvis
MRI in pregnancy when ultrasound is nondiagnostic
Clinical risk score as an adjunct, not a replacement for judgment

Gold-Standard Diagnostic Approach

CT provides high diagnostic accuracy in many adults, but diagnosis is based on integrated
clinical and imaging findings. Surgical pathology provides definitive confirmation after
appendectomy.

Conventional Treatment

Nothing by mouth
IV fluids
Analgesia
Antiemetic treatment
Preoperative antibiotics
Laparoscopic appendectomy for most operative cases
Broader antibiotic treatment for perforation or abscess
Drainage or interval management in selected appendiceal abscesses

Antibiotic-only treatment may be discussed for carefully selected uncomplicated cases, but
recurrence and missed complicated disease must be considered. Appendicolith and
complicated features reduce the suitability of nonoperative care.

Naturopathic Treatment Plan

There is no appropriate primary naturopathic treatment for suspected appendicitis.
After uncomplicated recovery:

Gradual return to normal diet and activity
Adequate protein and hydration
Wound-care support
Prevention of constipation without stimulant overuse
Monitoring for postoperative infection

Botanical and Supplement Safety

Do not give laxatives or enemas.
Avoid oral products when emergency anesthesia may be required.
Review garlic, ginkgo, turmeric and omega-3 products before surgery.
Do not mask progressive symptoms with sedating herbs.
Avoid abdominal massage or manipulation.
Do not use herbal antimicrobials instead of surgical assessment.

Urgent Referral Criteria

Rebound or guarding
Rigid abdomen
Hypotension
Persistent tachycardia
High fever
Increasing generalized pain
Sepsis
Repeated vomiting
Suspected perforation
Pregnancy with right-lower-quadrant pain

Clinical Pearl

In classic appendicitis, pain usually precedes vomiting; prominent vomiting before pain
suggests an alternative diagnosis.

NPLEX Examination Trap

Do not delay surgical evaluation because the patient is young, ambulatory or has only a modest
fever.

Disease Overview

Appendicitis usually results from luminal obstruction followed by inflammation, bacterial
proliferation, ischemia and possible perforation. Early recognition reduces the risk of abscess
and generalized peritonitis.

Most Likely Diagnosis

Adhesive small-bowel obstruction with dehydration

Differential Diagnosis

● Incarcerated hernia

Small-bowel tumour
Crohn stricture
Intussusception
Gallstone ileus
Volvulus
Paralytic ileus
Severe constipation
Mesenteric ischemia

Key Investigations

CBC
Electrolytes
Creatinine
Magnesium
Lactate
Venous or arterial blood gas
CT abdomen and pelvis with contrast when appropriate
Abdominal radiographs when CT is not immediately available
Urinalysis
Pregnancy testing when relevant

Gold-Standard Investigation

CT of the abdomen and pelvis is the principal diagnostic imaging test. It can identify the
transition point, cause and complications such as closed-loop obstruction, ischemia,
pneumatosis or perforation.

Conventional Treatment

NPO status
IV balanced crystalloid
Electrolyte replacement
Nasogastric decompression
Venous-thromboembolism prevention
Water-soluble contrast challenge in selected cases
Serial examinations and laboratory testing
Surgery for peritonitis, ischemia, perforation, closed-loop obstruction or failure of
nonoperative management

Postoperative adhesions are the leading cause of small-bowel obstruction, and evidence-based
pathways distinguish patients eligible for conservative treatment from those needing urgent
surgery.

Naturopathic Treatment Plan

There is no primary naturopathic treatment during acute obstruction.
Following recovery:

Gradual diet advancement
Hydration
Appropriate movement
Individualized fibre intake
Management of constipation
Monitoring for recurrence
Surgical follow-up when episodes are recurrent

Botanical and Supplement Safety

Avoid bulk-forming fibre during obstruction.
Avoid stimulant laxatives.
Avoid magnesium cathartics.
Avoid abdominal manipulation and castor-oil packs.
Avoid oral herbal products when vomiting is present.
Review supplements affecting bleeding before possible surgery.

Urgent Surgical Indicators

Peritonitis
Continuous rather than colicky pain
Fever
Persistent tachycardia
Rising lactate
Leukocytosis with deterioration
Metabolic acidosis
Closed-loop obstruction
Pneumatosis
Portal venous gas
Free intraperitoneal air

Clinical Pearl

A transition point with dilated proximal and collapsed distal bowel supports mechanical
obstruction rather than generalized ileus.

NPLEX Examination Trap

Do not prescribe fibre for every patient with constipation or absent stool passage. First exclude
mechanical obstruction.

Disease Overview

Small-bowel obstruction prevents forward movement of intestinal contents. Fluid sequestration,
vomiting and impaired absorption produce dehydration, while strangulation may progress to
ischemia, necrosis and perforation.

Most Likely Diagnosis

Acute complicated sigmoid diverticulitis with pericolic abscess

Differential Diagnosis

Colorectal cancer
Ischemic colitis
Inflammatory bowel disease
Infectious colitis

Pyelonephritis
Ovarian torsion
Pelvic inflammatory disease
Epiploic appendagitis

Key Investigations

CT abdomen and pelvis
CBC
CRP
Electrolytes and renal function
Blood cultures if septic
Urinalysis
Pregnancy test when relevant
Colonoscopy after recovery when indicated to exclude malignancy
Image-guided aspiration or drainage culture

Gold-Standard Investigation

Contrast-enhanced CT is the primary diagnostic test for suspected complicated diverticulitis.

Conventional Treatment

Hospital admission
IV fluids
Analgesia
Antibiotics covering appropriate intestinal organisms
Image-guided drainage of suitable abscesses
Surgery for generalized peritonitis, uncontrolled sepsis, fistula, obstruction or failed
nonoperative management
● Delayed colon evaluation after inflammation resolves when appropriate
Antibiotics can be used selectively in uncomplicated disease, but they are indicated in
complicated diverticulitis and in patients with systemic illness or significant risk factors.

Naturopathic Treatment Plan

During recovery:
● Advance diet according to symptoms and medical direction.
● Resume fibre gradually after acute inflammation resolves.
● Emphasize plant-rich dietary patterns.

Encourage regular physical activity.
Stop smoking.
Address obesity where relevant.
Maintain hydration.
Avoid chronic unnecessary NSAID use.

Botanical and Supplement Safety

Avoid stimulant laxatives during acute diverticulitis.
Avoid aggressive fibre loading during severe pain or obstruction.
Avoid strong antimicrobial herbs as substitutes for antibiotics and drainage.
Review garlic, ginkgo and curcumin before invasive drainage or surgery.
Avoid abdominal massage during acute inflammation.
Probiotics are not proven to prevent recurrent diverticulitis consistently.

Monitoring

Fever
Pain
WBC and CRP
Oral intake
Abscess size
Signs of obstruction
Sepsis
Recurrence
Need for follow-up colon evaluation

Urgent Referral Criteria

Generalized peritonitis
Hypotension
Persistent vomiting
Bowel obstruction
Free perforation
Uncontrolled abscess
Sepsis
Immunosuppression
Failure to improve
Significant rectal bleeding

Clinical Pearl

Diverticulitis becomes “complicated” when associated with abscess, fistula, obstruction,
stricture or perforation.

NPLEX Examination Trap

Do not perform routine colonoscopy during the acutely inflamed phase.

Disease Overview

Diverticulitis occurs when a colonic diverticulum becomes inflamed or perforates
microscopically. Disease may remain localized or progress to abscess, fistula, obstruction or
generalized peritonitis.

Most Likely Diagnosis

Acute gallstone pancreatitis

Differential Diagnosis

Perforated peptic ulcer
Acute cholecystitis
Acute cholangitis
Mesenteric ischemia
Myocardial infarction
Aortic dissection
Bowel obstruction
Diabetic ketoacidosis

Key Investigations

Lipase
CBC
Electrolytes and renal function
Glucose
Liver enzymes and bilirubin
Calcium
Triglycerides
Abdominal ultrasound
CT abdomen for diagnostic uncertainty, complications or failure to improve
MRCP or endoscopic ultrasound when retained common-duct stone is suspected
Oxygen saturation and organ-failure assessment

Gold-Standard Diagnostic Approach

Diagnosis is clinical and biochemical. CT is not required routinely when characteristic pain and
enzyme elevation establish the diagnosis.

Conventional Treatment

Analgesia
Antiemetic treatment
Moderate, reassessed IV crystalloid resuscitation
Early low-fat oral feeding in mild disease
Enteral tube feeding when oral intake is not possible
Treatment of organ failure
ERCP when acute cholangitis or persistent biliary obstruction is present
Same-admission cholecystectomy after recovery from mild gallstone pancreatitis

● Drainage or necrosectomy for selected infected or symptomatic necrotic collections
The 2024 ACG guideline supports early oral feeding, avoidance of routine prophylactic
antibiotics and urgent ERCP when pancreatitis is complicated by cholangitis.

Naturopathic Treatment Plan

After recovery:

Avoid alcohol.
Stop smoking.
Correct severe hypertriglyceridemia if present.
Follow an appropriate balanced diet.
Maintain healthy weight.
Do not postpone indicated gallbladder surgery.
Monitor for malabsorption if recurrent or chronic pancreatic injury develops.

Botanical and Supplement Safety

Avoid oral supplements during uncontrolled vomiting.
Avoid high-fat supplement preparations during early recovery.
Avoid alcohol-containing tinctures.
Review medications and supplements associated with pancreatitis.
Do not use pancreatic enzymes unless clinically indicated.
Do not substitute bitters or digestive herbs for cholecystectomy.

Monitoring

Vital signs
Urine output
Hematocrit
BUN and creatinine
Oxygenation
Electrolytes
Glucose
Oral tolerance
Organ failure
Infection or necrosis
Biliary obstruction

Urgent Referral Criteria

Hypotension
Respiratory failure
Acute kidney injury
Altered mental status
Rising lactate
Cholangitis
Persistent obstruction
Abdominal compartment syndrome
Infected necrosis
Multiorgan failure

Clinical Pearl

Lipase levels do not correlate reliably with pancreatitis severity and should not be
serially followed to determine recovery.

NPLEX Examination Trap

Do not order routine early CT merely to confirm classic pancreatitis already established by pain
and enzyme elevation.

Disease Overview

Acute pancreatitis results from premature pancreatic-enzyme activation and inflammation.
Gallstones and alcohol are common causes, but hypertriglyceridemia, medications,
hypercalcemia and other conditions must be considered.

Most Likely Diagnosis

Acute calculous cholecystitis

Differential Diagnosis

Biliary colic
Acute cholangitis
Gallstone pancreatitis
Hepatitis
Peptic-ulcer disease
Right-lower-lobe pneumonia
Pyelonephritis
Myocardial ischemia
Hepatic abscess

Key Investigations

CBC
CRP
Liver enzymes
Bilirubin
Lipase
Electrolytes and renal function
Right-upper-quadrant ultrasound
Hepatobiliary scintigraphy when ultrasound is equivocal
MRCP if common-duct stones are suspected
CT when complications or alternative diagnoses are considered

Gold-Standard Investigation

Ultrasound is the usual first-line test. Hepatobiliary scintigraphy is highly sensitive for cystic-duct
obstruction when ultrasound findings are uncertain.

Conventional Treatment

NPO status initially
IV fluids
Analgesia
Antiemetic therapy
Antibiotics according to severity
Early laparoscopic cholecystectomy
Percutaneous cholecystostomy for selected critically ill patients who cannot tolerate
surgery
● Evaluation for common-bile-duct stones
Initial management and procedural timing should be guided by severity, comorbidity and surgical
risk.

Naturopathic Treatment Plan

After treatment:

Gradual diet advancement
Moderate fat intake according to tolerance
Healthy weight management
Diabetes and lipid control
Smoking cessation
Avoidance of rapid crash diets
Postoperative nutrition and activity support

Botanical and Supplement Safety

Avoid gallbladder flushes.
Avoid forceful choleretic herbs during acute obstruction.
Avoid oral products during repeated vomiting.
Review bleeding-promoting supplements before surgery.
Peppermint may reduce spasm but does not treat infection or cystic-duct obstruction.
Do not postpone surgery for botanical therapy.

Urgent Referral Criteria

Hypotension
Confusion
Generalized peritonitis
Jaundice

Cholangitis
Gangrenous cholecystitis
Perforation
Emphysematous cholecystitis
Persistent vomiting
Sepsis

Clinical Pearl

Pain from acute cholecystitis is persistent and inflammatory; uncomplicated biliary colic
usually resolves after the obstruction passes.

NPLEX Examination Trap

Do not recommend a “gallbladder flush.” The material passed in stool does not prove gallstones
were expelled from the gallbladder.

Disease Overview

Acute calculous cholecystitis usually results from persistent cystic-duct obstruction by a
gallstone, causing gallbladder distension, inflammation and possible secondary infection.

Most Likely Diagnosis

Severe acute ascending cholangitis caused by common-bile-duct obstruction

Differential Diagnosis

Acute cholecystitis
Gallstone pancreatitis
Acute hepatitis
Hepatic abscess
Sepsis from another source
Malignant biliary obstruction
Primary sclerosing cholangitis complication
Hemolysis

Key Investigations

CBC
Blood cultures
Electrolytes and renal function
Liver enzymes and bilirubin
Coagulation studies
Lactate
Lipase
Right-upper-quadrant ultrasound
MRCP or CT when needed
ERCP for diagnosis and treatment

Gold-Standard Therapeutic Procedure
ERCP with biliary decompression is the preferred diagnostic and therapeutic procedure in
most patients with obstructive cholangitis.

Conventional Treatment

Sepsis resuscitation
Oxygen and hemodynamic monitoring
IV antibiotics
Vasopressors if shock persists
Urgent ERCP with sphincterotomy, stone extraction or stenting
Percutaneous or surgical drainage if ERCP is unavailable or unsuccessful
Definitive gallbladder treatment after stabilization when gallstones are the source

Antimicrobial therapy should be adjusted once culture and susceptibility results are available.

Naturopathic Treatment Plan

No acute naturopathic treatment is appropriate.
After recovery:

Complete definitive gallstone management.
Maintain balanced nutrition.
Avoid rapid weight-loss diets.
Address diabetes and metabolic risk.
Avoid unnecessary hepatotoxic products.
Support medication adherence and postoperative recovery.

Botanical and Supplement Safety

Avoid bitters, choleretics and gallbladder flushes during obstruction.
Avoid oral supplements in unstable patients.
Avoid potentially hepatotoxic herbs.
Review bleeding-promoting supplements before ERCP.
Do not use herbal antimicrobials instead of IV antibiotics.
Avoid products that may interact with anesthesia or antibiotics.

Monitoring

Blood pressure
Mental status
Urine output
Lactate
Bilirubin
Renal function
Temperature

● Blood cultures
● Response after decompression
● Post-ERCP pancreatitis or bleeding

Urgent Referral Criteria

All suspected cholangitis requires urgent assessment. Emergency decompression is particularly
important with:

Hypotension
Confusion
Renal dysfunction
Respiratory dysfunction
Coagulopathy
Thrombocytopenia
Persistent fever
Rising bilirubin
Septic shock

Clinical Pearl

Antibiotics alone may not control cholangitis when an infected biliary system remains
obstructed. Source control is essential.

NPLEX Examination Trap

Do not confuse cholangitis with uncomplicated cholecystitis. Jaundice and systemic toxicity
suggest common-bile-duct obstruction and infection.

Disease Overview

Ascending cholangitis is bacterial infection of an obstructed biliary system. Increased ductal
pressure promotes bacteremia and systemic sepsis.

Most Likely Diagnosis

Spontaneous bacterial peritonitis complicated by acute kidney injury and hepatic
encephalopathy

Differential Diagnosis

Secondary bacterial peritonitis from perforation
Acute cholecystitis
Pancreatitis
Urinary infection
Pneumonia
Portal-vein thrombosis
Hepatorenal syndrome
Gastrointestinal bleeding with encephalopathy

Key Investigations

Diagnostic paracentesis before antibiotics when this does not delay treatment
Ascitic cell count and differential
Ascitic culture inoculated into blood-culture bottles
Blood cultures
CBC
Electrolytes and creatinine

Liver tests
INR
Lactate
Urinalysis and urine culture
Chest imaging
CT abdomen if secondary peritonitis is suspected

Gold-Standard Diagnostic Criterion
Ascitic polymorphonuclear neutrophil count of at least 250 cells/mm³
A positive culture is not required.

Conventional Treatment

Prompt IV antibiotic therapy
IV albumin in appropriate patients
Hold nephrotoxic medications
Review or temporarily hold diuretics based on volume and renal status
Treat hepatic encephalopathy
Monitor for septic shock and hepatorenal syndrome
Repeat paracentesis when response is inadequate or secondary peritonitis is suspected
Secondary antibiotic prophylaxis after recovery, individualized according to current
guidance and resistance concerns
● Liver-transplant evaluation after decompensation
Antibiotic prophylaxis can reduce recurrent SBP risk, but selection should consider antimicrobial
resistance and individual risk rather than indiscriminate use.

Naturopathic Treatment Plan

No naturopathic treatment can replace antibiotics.
After stabilization:

Complete alcohol abstinence.
Maintain adequate protein unless a specific temporary contraindication exists.
Use individualized sodium restriction.
Avoid prolonged fasting.
Support medication adherence.
Prevent constipation.
Maintain vaccination and infection-prevention measures.
Coordinate transplant and hepatology care.

Botanical and Supplement Safety

Avoid NSAID-containing products and willow bark.
Avoid hepatotoxic herbs.
Avoid high-dose diuretic herbs.
Avoid raw or undercooked shellfish.
Avoid sedating products that worsen encephalopathy.
Avoid potassium supplements without laboratory monitoring.
Review every supplement because cirrhosis alters metabolism and increases toxicity
risk.

Monitoring

Mental status
Blood pressure
Urine output
Creatinine
Sodium
Ascitic neutrophil response
Lactate
Gastrointestinal bleeding
Respiratory status
Recurrent infection

Urgent Referral Criteria

Hypotension
Rising creatinine
Oliguria
Worsening encephalopathy
Hypoxemia
Lactic acidosis
Gastrointestinal bleeding
Rigid abdomen
Free air
Failure of ascitic neutrophils to fall with treatment

Clinical Pearl

Cirrhotic patients with SBP may have only mild abdominal tenderness; confusion or
kidney injury may be the dominant presentation.

NPLEX Examination Trap

Do not wait for ascitic-fluid culture results when the neutrophil count meets diagnostic criteria.

Disease Overview

SBP is infection of ascitic fluid without an evident surgically treatable intra-abdominal source.
Impaired immune function and bacterial translocation in advanced cirrhosis contribute to its
development.

Most Likely Diagnosis

Acetaminophen-induced acute liver failure

Differential Diagnosis

Ischemic hepatitis
Acute viral hepatitis
Autoimmune hepatitis
Wilson disease
Amanita mushroom poisoning
Drug-induced liver injury
Acute Budd–Chiari syndrome
Acute fatty liver of pregnancy
HELLP syndrome

Key Investigations

Acetaminophen concentration
AST and ALT
Bilirubin
INR and coagulation profile
Glucose
Electrolytes
Creatinine
Blood gas and lactate
CBC
Viral-hepatitis testing
Autoimmune markers
Pregnancy testing
Ceruloplasmin and hemolysis assessment in younger patients
Toxicology screening
Liver ultrasound with vascular Doppler
Frequent neurological assessment

Gold-Standard Diagnostic Approach

Diagnosis is based on clinical history and biochemical pattern. Acetaminophen-protein-adduct
testing may help in uncertain cases but is not routinely available.

Conventional Treatment

Immediate IV N-acetylcysteine
Intensive-care management
Transplant-centre consultation
Frequent glucose monitoring and correction
Careful fluid and vasopressor management
Management of cerebral edema
Treatment of infection
Renal-replacement therapy when indicated
Avoidance of sedatives when possible
Serial INR, lactate, pH and neurological assessment
Emergency liver transplantation when prognostic criteria indicate poor spontaneous
recovery

AASLD notes that very high aminotransferases with relatively low bilirubin in acute liver failure
strongly suggest acetaminophen or ischemic injury.

Naturopathic Treatment Plan

There is no acute naturopathic treatment.
After recovery:

Review every prescription and over-the-counter product.
Teach the patient to identify duplicate acetaminophen ingredients.
Avoid alcohol during recovery.
Avoid unnecessary supplements.
Address the reason for excess dosing.
Provide mental-health assessment if intentional ingestion is possible.
Monitor for residual liver or kidney dysfunction.

Botanical and Supplement Safety

Stop all nonessential supplements.
Avoid kava, comfrey, chaparral and other potentially hepatotoxic products.
Avoid concentrated green-tea extracts.
Avoid alcohol-containing tinctures.
Milk thistle is not an antidote to acetaminophen.
Herbal and dietary supplements can themselves cause severe liver injury.

● Do not give oral products to a confused patient because of aspiration risk.

Monitoring

Mental status
INR
Glucose
Lactate
pH
Creatinine
Urine output
AST and ALT trends
Bilirubin
Hemodynamic status
Cerebral-edema signs
Transplant eligibility

Urgent Referral Criteria

All acute liver failure requires urgent specialist referral, particularly with:

Encephalopathy
Rising INR
Metabolic acidosis
Elevated lactate
Hypoglycemia
Acute kidney injury
Hypotension
Cerebral edema
Rapid progression
Suspected Wilson disease
Pregnancy-associated liver failure

Clinical Pearl

Start N-acetylcysteine when acetaminophen toxicity is possible; do not wait for certainty
in a deteriorating patient.

NPLEX Examination Trap

Do not use the Rumack–Matthew nomogram for repeated dosing, delayed presentations or an
unknown ingestion time.

Disease Overview

Acetaminophen toxicity depletes hepatic glutathione, allowing the toxic metabolite NAPQI to
damage hepatocytes. Early N-acetylcysteine replenishes glutathione and improves hepatic
blood flow and antioxidant capacity.

Most Likely Diagnosis

Acute esophageal variceal hemorrhage caused by portal hypertension

Differential Diagnosis

Peptic-ulcer bleeding
Portal-hypertensive gastropathy
Gastric varices
Erosive gastritis
Mallory–Weiss tear
Gastric malignancy
Dieulafoy lesion

Key Investigations

CBC
Type and crossmatch
Electrolytes and creatinine
Liver tests
INR and fibrinogen
Lactate
Blood gas
ECG
Urgent upper endoscopy
Diagnostic paracentesis if infection is possible
Doppler ultrasound or portal imaging after stabilization

Gold-Standard Diagnostic and Therapeutic Procedure
Urgent upper endoscopy identifies the bleeding lesion and permits endoscopic variceal
ligation.

Conventional Treatment

Airway protection when aspiration risk is high
Restrictive, individualized red-cell transfusion
IV vasoactive treatment such as octreotide
IV antibiotic prophylaxis
Endoscopic band ligation
Balloon tamponade or an esophageal stent as a temporary bridge in uncontrolled
bleeding
● Transjugular intrahepatic portosystemic shunt for selected high-risk patients or
uncontrolled hemorrhage
● Secondary prevention with a nonselective beta-blocker and repeat ligation after recovery

Patients who have experienced decompensating complications of cirrhosis should also be
considered for liver-transplant evaluation.

Naturopathic Treatment Plan

There is no naturopathic treatment for acute variceal hemorrhage.
After stabilization:

Complete abstinence from alcohol
Adequate protein and calorie intake
Individualized sodium restriction for ascites
Avoidance of prolonged fasting
Medication adherence
Prevention of constipation
Hepatology and transplant follow-up
Vaccination and infection-prevention support

Botanical and Supplement Safety

Avoid:

Garlic
Ginkgo
Willow bark
High-dose ginger
Concentrated turmeric
High-dose omega-3 products
Hepatotoxic botanicals
Alcohol-containing tinctures
Unmonitored diuretic herbs

Monitoring

Recurrent hematemesis or melena
Blood pressure and heart rate
Hemoglobin
Creatinine and urine output
Mental status
Ascites
Infection
Rebleeding after endoscopic treatment

Clinical Pearl

Begin vasoactive medication and antibiotic therapy when variceal bleeding is suspected;
do not wait for endoscopy.

NPLEX Examination Trap

Do not aggressively transfuse every patient to a normal hemoglobin. Excessive intravascular
volume can increase portal pressure and contribute to recurrent bleeding.

Disease Overview

Portal hypertension creates collateral veins between the portal and systemic circulation.
Esophageal varices may rupture when wall tension exceeds their capacity, producing massive
gastrointestinal hemorrhage.

Most Likely Diagnosis

Overt hepatic encephalopathy precipitated by constipation, sedative exposure and
possible dehydration or infection

Differential Diagnosis

Sepsis-associated delirium
Intracranial hemorrhage
Ischemic stroke
Hypoglycemia
Hyponatremia
Uremia
Alcohol withdrawal
Wernicke encephalopathy
Medication toxicity
Nonconvulsive seizure

Key Investigations

Point-of-care glucose
CBC
Electrolytes and creatinine
Liver tests
INR
Blood and urine cultures
Diagnostic paracentesis
Assessment for gastrointestinal bleeding
Medication and supplement review

● Brain imaging for trauma, focal findings or diagnostic uncertainty
● Toxicology testing when indicated

Gold-Standard Diagnostic Approach

Hepatic encephalopathy is a clinical diagnosis of exclusion in a patient with liver dysfunction
or portosystemic shunting.
An elevated ammonia level may support impaired nitrogen metabolism but does not replace
clinical assessment.

Conventional Treatment

Correct the precipitating cause.
Use lactulose, adjusted to achieve regular soft bowel movements.
Add rifaximin for recurrent episodes or inadequate prevention.
Treat infection or gastrointestinal bleeding.
Correct dehydration and electrolyte abnormalities.
Stop unnecessary sedatives.
Consider shunt-related causes in recurrent refractory disease.
Assess for liver transplantation.

Naturopathic Treatment Plan

After stabilization:

Avoid alcohol.
Maintain adequate protein, preferably distributed throughout the day.
Use a late-evening nutritional snack when appropriate.
Prevent constipation.
Maintain appropriate hydration.
Support medication adherence.
Avoid prolonged fasting.
Address sarcopenia with nutrition and medically appropriate exercise.

Botanical and Supplement Safety

Avoid:
● Valerian and other sedating products
● Kava
● High-dose melatonin without review

Cannabis products that worsen cognition
Opioid-like herbal products
Strong diuretic herbs
Hepatotoxic supplements
Magnesium laxatives in renal impairment

Monitoring

Mental status
Bowel-movement frequency
Hydration
Sodium and potassium
Creatinine
Infection
Gastrointestinal bleeding
Falls
Medication adherence
Recurrent admissions

Urgent Referral Criteria

Reduced consciousness
Inability to protect the airway
Seizure
Focal neurological deficit
Fever or sepsis
Gastrointestinal bleeding
Severe hypoglycemia
Acute kidney injury
Rapidly worsening jaundice
Suspected intracranial bleeding

Clinical Pearl

The priority in hepatic encephalopathy is not simply lowering ammonia—it is finding and
correcting the precipitating event.

NPLEX Examination Trap

Do not permanently eliminate protein. Malnutrition and loss of muscle reduce the body’s ability
to metabolize ammonia.

Disease Overview

Hepatic encephalopathy is a potentially reversible neuropsychiatric syndrome caused by liver
dysfunction and portosystemic shunting. Ammonia and other neurotoxins impair astrocyte and
neuronal function.

Most Likely Diagnosis

Acute diverticular lower gastrointestinal hemorrhage

Differential Diagnosis

Angiodysplasia
Colorectal cancer
Ischemic colitis
Inflammatory bowel disease
Post-polypectomy bleeding
Hemorrhoids
Rectal varices
Brisk upper gastrointestinal bleeding

Key Investigations

CBC
Type and crossmatch
Electrolytes and creatinine
Coagulation studies
Lactate
Upper endoscopy when an upper source is possible
CT angiography during ongoing severe bleeding
Colonoscopy after stabilization and bowel preparation
Catheter angiography for embolization when indicated

Gold-Standard Diagnostic Approach

Colonoscopy is the standard diagnostic and potentially therapeutic test in most stabilized
patients.
CT angiography is especially valuable when active, hemodynamically significant bleeding is
ongoing and rapid localization is needed.

Conventional Treatment

IV fluid and blood-product resuscitation
Individualized management of antithrombotic medications
Endoscopic clipping, coagulation or other hemostasis
Angiographic embolization for ongoing localized bleeding
Surgery for uncontrolled hemorrhage after other measures fail
Avoidance of nonessential NSAIDs
Evaluation for colorectal neoplasia when appropriate

Diverticular bleeding is commonly painless and may stop spontaneously, but severe cases
require endoscopic, radiological or surgical control.

Naturopathic Treatment Plan

No natural treatment is appropriate during active major bleeding.
After stabilization:

Stop unnecessary NSAIDs.
Maintain appropriate fibre intake after bleeding resolves.
Avoid constipation and straining.
Support iron replacement when deficiency is confirmed.
Maintain hydration.
Complete recommended colon evaluation.

Botanical and Supplement Safety

Review or avoid:

Garlic
Ginkgo
Willow bark
High-dose ginger
Turmeric extracts
High-dose omega-3 products
Dong quai
Unregulated anticoagulant supplements

Monitoring

Recurrent hematochezia
Orthostatic symptoms
Hemoglobin
Renal function
Medication exposure
Need for transfusion
Post-embolization ischemia
Recurrent bleeding after discharge

Clinical Pearl

Large-volume painless hematochezia in an older adult commonly suggests diverticular
bleeding or angiodysplasia, but brisk upper bleeding must still be considered.

NPLEX Examination Trap

Do not automatically diagnose hemorrhoids whenever bright-red blood is present.

Disease Overview

Diverticular bleeding occurs when a branch of the colonic artery associated with a diverticulum
becomes eroded and ruptures. It often presents suddenly and without abdominal pain.

Most Likely Diagnosis

MASLD with an intermediate noninvasive risk of liver fibrosis

Differential Diagnosis

Alcohol-associated liver disease
Chronic viral hepatitis
Autoimmune hepatitis
Hemochromatosis
Wilson disease
Medication-induced steatosis
Hypothyroidism
Celiac disease

Key Investigations

CBC and platelets
ALT, AST, bilirubin and albumin
HbA1c
Lipid profile
Viral-hepatitis testing
Iron studies
Autoimmune testing when indicated
FIB-4 or another validated blood-based score
Transient elastography
MRI-based assessment in selected patients
Liver biopsy when noninvasive tests are discordant or a definitive diagnosis is required

Gold-Standard Investigation

Liver biopsy is the reference standard for distinguishing steatosis from steatohepatitis and
directly staging fibrosis, but it is not required for every patient.

Conventional Treatment

● Sustained weight loss

Management of diabetes
Blood-pressure control
Statin therapy when indicated
Treatment of sleep apnea
Regular aerobic and resistance activity
Avoidance of excessive alcohol
Consideration of metabolic or weight-management pharmacotherapy
Bariatric surgery in appropriate candidates
Cirrhosis surveillance when advanced fibrosis is present

AASLD updated its MASLD guidance in 2025 to incorporate evidence-based selection and
monitoring for semaglutide therapy in appropriate patients with metabolic steatohepatitis.

Naturopathic Treatment Plan

Mediterranean-style eating pattern
Reduced refined carbohydrates and sugar-sweetened drinks
Increased vegetables, legumes, whole grains and unsaturated fats
Gradual calorie reduction
Regular resistance and aerobic exercise
Sleep optimization
Management of obstructive sleep apnea
Behavioural support for sustainable weight loss

Botanical and Supplement Safety

Avoid kava, comfrey, chaparral and other hepatotoxic botanicals.
Avoid concentrated green-tea extract.
Avoid high-dose vitamin E without individualized risk assessment.
Do not assume milk thistle reverses fibrosis.
Review supplements for hidden anabolic steroids or weight-loss stimulants.
Statins should not be automatically stopped solely because MASLD is present.

Monitoring

Weight and waist circumference
HbA1c
Lipids
Blood pressure
Liver enzymes
Fibrosis markers
Elastography
Cardiovascular risk

● Signs of cirrhosis
● Hepatocellular-carcinoma surveillance when indicated

Clinical Pearl

Fibrosis stage—not liver-fat quantity—is the strongest liver-related prognostic marker in
MASLD.

NPLEX Examination Trap

Do not reassure a high-risk diabetic patient based only on mildly elevated liver enzymes.
Significant fibrosis may exist even when aminotransferases are only modestly abnormal.

Disease Overview

MASLD is hepatic steatosis occurring in association with metabolic dysfunction. Insulin
resistance, adipose inflammation and lipotoxicity may lead to hepatocellular injury,
steatohepatitis and progressive fibrosis.

Most Likely Diagnosis

Right-sided colorectal adenocarcinoma until proven otherwise

Differential Diagnosis

Bleeding colonic polyp
Angiodysplasia
Celiac disease
Peptic-ulcer disease
Crohn disease
Gastric cancer
Chronic NSAID-related bleeding
Iron-deficient diet with another source of blood loss

Key Investigations

Colonoscopy with biopsy
CBC and iron studies
Upper endoscopy when indicated
CT chest, abdomen and pelvis for staging after diagnosis
Liver tests
CEA as a baseline prognostic and surveillance marker
Tumour mismatch-repair or microsatellite-instability testing
Genetic assessment when hereditary cancer is possible

Gold-Standard Investigation

Histopathological examination of colonoscopic biopsy tissue confirms colorectal cancer.

Conventional Treatment

Treatment depends on tumour location, stage, molecular characteristics and functional status
and may include:

Surgical resection
Adjuvant chemotherapy
Radiation therapy for selected rectal cancers
Targeted therapy
Immunotherapy
Treatment of obstruction or bleeding
Iron replacement and nutritional rehabilitation

● Surveillance colonoscopy and imaging
Colorectal cancer may present with rectal bleeding, altered bowel habits, anemia, weight loss or
abdominal pain, although early disease may be asymptomatic.

Naturopathic Treatment Plan

Integrative supportive care may include:

Nutritional assessment
Correction of iron and protein-calorie deficiency
Safe physical activity
Smoking cessation
Limitation of alcohol
Management of treatment-associated symptoms
Psychological and caregiver support
Coordination with oncology

Botanical and Supplement Safety

Stop bleeding-promoting supplements before biopsy or surgery when advised.
Avoid products claiming to cure cancer.
Avoid St. John’s wort because of major drug interactions.
Do not assume high-dose antioxidants are safe during chemotherapy or radiation.
Review probiotics during severe neutropenia.
Do not delay surgery or staging for dietary or botanical treatment.

Urgent Referral Criteria

Complete bowel obstruction
Perforation
Peritonitis
Major bleeding
Severe symptomatic anemia
Persistent vomiting
Rapid abdominal distension
Sepsis
New neurological symptoms suggesting metastasis

Clinical Pearl

Right-sided colorectal cancers often present with occult blood loss and iron-deficiency
anemia rather than obvious hematochezia.

NPLEX Examination Trap

Do not treat unexplained iron-deficiency anemia in an adult without evaluating for
gastrointestinal malignancy.

Disease Overview

Most colorectal cancers develop through progressive genetic and epigenetic changes in
adenomatous or serrated precursor lesions. Screening can detect and remove precancerous
polyps before invasive cancer develops.

Most Likely Diagnosis

Type 2 diabetes mellitus with established atherosclerotic cardiovascular disease and
early albuminuric kidney involvement

Differential Diagnosis

Type 1 diabetes
Latent autoimmune diabetes in adults
Medication-induced diabetes
Pancreatic diabetes
Monogenic diabetes
Stress hyperglycemia
Diabetes insipidus as a cause of polyuria

Key Investigations

Repeat HbA1c or plasma glucose confirmation
Renal function
Urine albumin-creatinine ratio
Lipid profile
Liver tests
Blood pressure
Dilated retinal assessment
Foot and neurological examination
Vitamin B12 monitoring if long-term metformin is used
Autoantibodies or C-peptide when diabetes type is uncertain

Conventional Treatment

Potential components include:
● Metformin when appropriate
● GLP-1 receptor agonist with proven cardiovascular benefit
● SGLT2 inhibitor for cardiorenal protection when appropriate

Statin therapy
ACE inhibitor or ARB for hypertension with albuminuria
Nutrition and weight-management therapy
Regular physical activity
Glucose monitoring individualized to treatment
Diabetes education
Vaccination and preventive care

The ADA publishes updated Standards of Care annually; the 2026 standards emphasize
individualized therapy and integrated cardiovascular, renal and weight management.

Naturopathic Treatment Plan

Use a high-fibre Mediterranean-style dietary pattern.
Reduce refined carbohydrates and sugary beverages.
Emphasize vegetables, legumes and minimally processed foods.
Distribute carbohydrate intake consistently.
Perform regular aerobic and resistance exercise.
Pursue gradual sustained weight loss.
Optimize sleep and treat sleep apnea.
Support smoking cessation.

Botanical and Supplement Safety

● Berberine may cause gastrointestinal effects and drug interactions and should not
replace proven therapy.
● Cinnamon products vary substantially and may contain hepatotoxic coumarin.
● Bitter melon and gymnema may increase hypoglycemia risk when combined with
medication.
● Avoid potassium supplementation without renal and medication review.
● Review all products before surgery or contrast imaging.
● Do not discontinue antihyperglycemic medication because a supplement was started.

Monitoring

HbA1c
Home or continuous glucose data when indicated
Blood pressure
Lipids
Weight
Kidney function
Albuminuria
Eye health

● Foot health
● Hypoglycemia
● Medication adverse effects

Clinical Pearl

Modern type 2 diabetes treatment is not based on HbA1c alone; cardiovascular, kidney
and weight outcomes influence medication choice.

NPLEX Examination Trap

Do not automatically start with glucose-lowering intensity alone while ignoring established
cardiovascular disease and albuminuria.

Disease Overview

Type 2 diabetes results from insulin resistance combined with progressive pancreatic beta-cell
dysfunction. Chronic hyperglycemia damages microvascular tissues and accelerates
cardiovascular and kidney disease.

Most Likely Diagnosis

Diabetic ketoacidosis precipitated by infection and insulin omission

Differential Diagnosis

Hyperosmolar hyperglycemic state
Starvation ketosis
Alcoholic ketoacidosis
Lactic acidosis
Salicylate toxicity
Sepsis
Acute abdomen
Pregnancy-related ketosis

Key Investigations

Glucose
Beta-hydroxybutyrate
Electrolytes
Bicarbonate
Venous pH
Anion gap

Creatinine
Magnesium and phosphate
CBC
Urinalysis
Pregnancy test when relevant
ECG
Infection evaluation
Troponin when cardiac ischemia is suspected

Gold-Standard Diagnostic Approach

Diagnosis requires evidence of:
● Diabetes or hyperglycemia
● Significant ketonemia
● Metabolic acidosis
DKA can occur with only modest glucose elevation, especially with SGLT2-inhibitor exposure,
pregnancy or reduced carbohydrate intake.

Conventional Treatment

Isotonic IV fluid replacement
IV insulin for severe DKA
Potassium replacement based on serum level and urine output
Addition of dextrose as glucose falls while insulin continues to clear ketosis
Frequent glucose, electrolyte, ketone and acid-base monitoring
Treatment of infection, infarction or another trigger
Transition to a subcutaneous insulin regimen after resolution

Naturopathic Treatment Plan

There is no acute naturopathic treatment.
Prevention includes:

Sick-day rules
Continued basal insulin
Frequent glucose and ketone monitoring during illness
Adequate fluid intake
Clear instructions for seeking emergency help
Ensuring access to insulin and supplies
Avoiding extreme carbohydrate restriction in insulin-dependent patients

Botanical and Supplement Safety

● Do not use glucose-lowering herbs in place of insulin.
● Avoid potassium supplements without laboratory monitoring.
● Avoid SGLT2 inhibitors during significant illness, fasting or perioperative periods
according to medical guidance.
● Avoid alcohol.
● Do not use ketogenic diets without close specialist oversight in insulin-treated diabetes.
● Stop nonessential supplements during acute treatment.

Monitoring

Hourly glucose
Potassium
Sodium
Bicarbonate
Venous pH
Beta-hydroxybutyrate
Anion gap
Urine output
Mental status
Cardiac rhythm

Urgent Referral Criteria

All suspected DKA requires urgent assessment, particularly with:

Vomiting
Abdominal pain
Deep rapid breathing
Positive ketones
Dehydration
Altered consciousness
Hypotension
Pregnancy
Inability to retain fluids

Clinical Pearl

A high initial serum potassium does not mean the body has excess potassium;
total-body potassium is usually depleted in DKA.

NPLEX Examination Trap

Do not stop insulin because the patient is unable to eat. Insulin omission during illness is a
common precipitant of DKA.

Disease Overview

DKA results from severe insulin deficiency and excess counter-regulatory hormones. Lipolysis
produces ketone bodies, causing anion-gap metabolic acidosis, osmotic diuresis and profound
electrolyte loss.

Most Likely Diagnosis

Hyperosmolar hyperglycemic state precipitated by urinary infection

Differential Diagnosis

Diabetic ketoacidosis
Sepsis-associated encephalopathy
Stroke
Hypernatremic dehydration
Medication toxicity
Uremia
Myxedema coma
Nonketotic lactic acidosis

Key Investigations

Glucose
Measured and calculated osmolality
Electrolytes
Corrected sodium
Potassium
Creatinine
Venous pH and bicarbonate
Beta-hydroxybutyrate
CBC
Cultures
Urinalysis
ECG
Chest imaging
Neurological imaging when indicated

Gold-Standard Diagnostic Approach

HHS is diagnosed through the combination of:

Severe hyperglycemia
Marked hyperosmolality
Dehydration
Absence of major ketoacidosis
Altered neurological status in many patients

Mixed DKA-HHS presentations can occur and should be treated according to the clinically
significant abnormalities.

Conventional Treatment

IV isotonic fluid
Slower replacement when heart or kidney failure limits volume tolerance
Potassium and electrolyte monitoring
IV insulin
Gradual correction of glucose and osmolality
Infection treatment
Thrombosis prevention when indicated
Careful transition to a long-term diabetes regimen
Education and support to prevent recurrence

Naturopathic Treatment Plan

There is no acute natural treatment.
After recovery:

Ensure access to water and medication.
Create sick-day instructions.
Simplify medication schedules where appropriate.
Assess cognition and caregiver support.
Improve glucose monitoring.
Address infection prevention.
Optimize nutrition and hydration.

Botanical and Supplement Safety

● Stop metformin during severe dehydration, shock or acute kidney injury according to
medical direction.
● Avoid diuretic herbs.
● Avoid sugar-containing electrolyte drinks unless incorporated into the medical plan.
● Avoid glucose-lowering supplements that obscure medication requirements.
● Avoid magnesium and potassium supplements without laboratory monitoring.

Monitoring

● Neurological status
● Blood pressure

Glucose
Sodium
Potassium
Osmolality
Urine output
Creatinine
Fluid balance
Signs of heart failure
Thrombosis

Urgent Referral Criteria

All suspected HHS requires emergency care, especially with:

Confusion
Seizure
Severe dehydration
Hypotension
Glucose markedly above usual levels
Acute kidney injury
Infection
Inability to drink
Frailty or lack of caregiver support

Clinical Pearl

Fluid replacement is the first major therapeutic intervention in HHS because the volume
deficit is usually profound.

NPLEX Examination Trap

Do not lower glucose and osmolality too rapidly. Sudden osmotic shifts may contribute to
neurological injury.

Disease Overview

HHS occurs when relative insulin sufficiency limits major ketogenesis but is inadequate to
control glucose. Extreme hyperglycemia causes osmotic diuresis, severe water loss and rising
serum osmolality.

Most Likely Diagnosis

Overt primary hypothyroidism caused by Hashimoto autoimmune thyroiditis

Differential Diagnosis

Central hypothyroidism
Medication-induced hypothyroidism
Iodine deficiency or excess
Postpartum thyroiditis
Nonthyroidal illness
Depression
Anemia
Obstructive sleep apnea
Adrenal insufficiency

Key Investigations

TSH
Free T4
Thyroid peroxidase antibodies
CBC
Ferritin and vitamin B12 when indicated
Lipid profile
Sodium
Creatine kinase when myopathy is present
Pregnancy testing when relevant
Pituitary evaluation when free T4 is low without an elevated TSH

Gold-Standard Diagnostic Approach

Primary hypothyroidism is diagnosed biochemically by elevated TSH with low free T4.
Antibody testing helps identify autoimmune etiology but is not required repeatedly once
established.

Conventional Treatment

Levothyroxine
Lower initial doses in older adults or people with significant coronary disease
Consistent daily administration
Repeat TSH after an appropriate interval following dose changes
Adjustment for pregnancy
Investigation of adherence, malabsorption or interactions if unusually high doses are
required

Naturopathic Treatment Plan

Ensure adequate but not excessive iodine intake.
Correct iron, B12, vitamin D or selenium deficiency when confirmed.
Use a balanced high-fibre diet.
Increase physical activity gradually.
Address sleep apnea and depression.
Separate levothyroxine from interfering supplements and foods.
Avoid unnecessary gluten restriction unless celiac disease is present.

Botanical and Supplement Safety

Calcium and iron can impair levothyroxine absorption.
Fibre supplements may affect absorption.
Biotin can interfere with thyroid laboratory tests.
Ashwagandha may increase thyroid-hormone levels in some users.
Kelp products may contain unpredictable iodine doses.
Avoid thyroid glandular products because hormone content may be undisclosed.
Do not combine prescription thyroid hormone with weight-loss stimulants.

Monitoring

TSH
Symptoms
Heart rate
Weight
Lipids
Pregnancy status
Adherence
Medication and supplement timing
Signs of overreplacement such as tremor, palpitations or bone loss

Urgent Referral Criteria

Severe bradycardia
Hypothermia
Reduced consciousness
Hypoventilation
Hypotension
Severe hyponatremia
Suspected myxedema coma
Pregnancy with uncontrolled hypothyroidism
Pituitary or adrenal dysfunction

Clinical Pearl

Levothyroxine should be taken consistently and separated from iron, calcium and other
products that impair absorption.

NPLEX Examination Trap

Do not automatically prescribe iodine for autoimmune hypothyroidism. Excess iodine can
worsen thyroid dysfunction.

Disease Overview

Primary hypothyroidism occurs when the thyroid cannot produce adequate hormone. Reduced
thyroid activity slows metabolic processes and affects cardiovascular, gastrointestinal,
neurological, reproductive and musculoskeletal function.

Most Likely Diagnosis

Thyroid storm precipitated by pneumonia in untreated Graves disease

Differential Diagnosis

Sepsis
Pheochromocytoma crisis
Serotonin syndrome
Neuroleptic malignant syndrome
Malignant hyperthermia
Cocaine or amphetamine toxicity
Severe panic disorder
Heat stroke
Anticholinergic toxicity

Key Investigations

Treatment should begin immediately while testing proceeds:

TSH
Free T4 and T3
CBC
Electrolytes
Glucose
Liver and renal function
ECG
Troponin
Cultures
Chest radiograph
Pregnancy test
Thyroid-receptor antibodies
Evaluation for heart failure

Gold-Standard Diagnostic Approach

There is no single laboratory threshold defining thyroid storm.
Diagnosis is based on severe thyrotoxicosis accompanied by systemic decompensation.
Scoring systems may support but must not replace clinical judgment.

Conventional Treatment

Intensive-care monitoring
Beta-blocker selected according to hemodynamic status
Propylthiouracil or methimazole
Iodine after antithyroid treatment
Glucocorticoid
Cooling measures
Acetaminophen rather than aspirin
Oxygen and heart-failure treatment
Antibiotics for bacterial infection
Cholestyramine in selected cases
Plasma exchange or emergency surgery in rare refractory cases

The ATA lists its 2016 hyperthyroidism guideline as the principal current general guideline for
diagnosis and management of thyrotoxicosis outside pregnancy-specific care.

Naturopathic Treatment Plan

There is no acute naturopathic treatment.
After recovery:

Avoid iodine-containing supplements.
Stop stimulant products.
Support adequate nutrition during recovery.
Avoid smoking, particularly with thyroid eye disease.
Maintain antithyroid-medication adherence.
Arrange definitive treatment discussion.
Manage infection and stress triggers.

Botanical and Supplement Safety

Avoid:

Kelp and iodine drops
Ashwagandha
Guggul
Thyroid glandular products
Bitter orange
Yohimbe
Ephedra-like stimulants
High-dose caffeine
Aspirin during thyroid storm
Unreviewed products that interact with antithyroid medications

Biotin should be stopped before thyroid testing when medically appropriate because it can
distort some immunoassay results.

Monitoring

Temperature
Heart rate and rhythm
Blood pressure
Mental status
Heart failure
Liver function
Glucose
Electrolytes
White-cell count
Thyroid-hormone levels
Response to infection treatment

Urgent Referral Criteria

Every suspected thyroid storm is an emergency, especially with:

Fever
Delirium
Seizure
Severe tachycardia
Atrial fibrillation
Heart failure
Hypotension
Jaundice
Vomiting or diarrhea
Multiorgan dysfunction

Clinical Pearl

Thyroid storm is defined by systemic decompensation, not simply by how high the free
T4 level is.

NPLEX Examination Trap

Do not administer iodine before blocking thyroid-hormone synthesis with an antithyroid
medication.

Disease Overview

Thyroid storm is the most severe manifestation of thyrotoxicosis. Excess thyroid hormone
amplifies adrenergic activity, oxygen consumption and heat production, leading to
cardiovascular, neurological, gastrointestinal and hepatic failure.

Most Likely Diagnosis

Autoimmune primary adrenal insufficiency presenting with adrenal crisis

Differential Diagnosis

Septic shock
Acute gastroenteritis with dehydration
Hypovolemic shock
Secondary adrenal insufficiency
Glucocorticoid-withdrawal syndrome
Diabetic ketoacidosis
Acute abdomen
Severe hypothyroidism
Medication-induced hyperkalemia

Key Investigations

Treatment and testing should occur simultaneously:

Serum cortisol
Plasma ACTH
Electrolytes
Glucose
Creatinine
CBC
Blood cultures
Renin and aldosterone after stabilization
Corticotropin-stimulation test when clinically stable
Adrenal antibodies
Thyroid and autoimmune screening
Adrenal imaging when hemorrhage, infection, infiltration or malignancy is suspected

Gold-Standard Confirmatory Investigation
Standard-dose corticotropin-stimulation testing is the preferred confirmatory test when the
patient’s condition permits. A high ACTH level in confirmed cortisol deficiency supports primary
rather than secondary adrenal insufficiency.

Conventional Treatment

Acute Crisis
● Immediate IV hydrocortisone
● Rapid isotonic crystalloid replacement
● IV dextrose when hypoglycemic

Cardiac monitoring
Electrolyte management
Treatment of infection or another precipitating factor
Vasopressor support if hypotension persists despite hormone and fluid replacement

Long-Term Management

Oral glucocorticoid replacement
Fludrocortisone when mineralocorticoid deficiency is present
Sick-day dose escalation
Emergency injectable hydrocortisone kit
Medical-alert identification
Education regarding vomiting, surgery, fever and trauma
Screening for associated autoimmune disease

Naturopathic Treatment Plan

Adjunctive measures after stabilization include:

Adequate salt and fluid intake according to endocrinology guidance
Regular balanced meals
Avoidance of prolonged fasting
Stress-dose planning before procedures
Infection-prevention measures
Support for adherence and emergency preparedness
Correction of documented nutritional deficiencies

Botanical and Supplement Safety

Do not use Glycyrrhiza glabra as cortisol replacement.
Avoid potassium supplements unless specifically prescribed.
Avoid strong diuretic herbs.
Avoid adrenal glandular products with undisclosed steroid content.
Review supplements that accelerate glucocorticoid metabolism.
Do not abruptly discontinue prescription glucocorticoids.
Avoid prolonged fasting and aggressive “detoxification” programs.

Monitoring

Blood pressure, including postural measurements
Sodium and potassium
Weight and edema
Energy and gastrointestinal symptoms

Glucocorticoid overreplacement
Renin when adjusting fludrocortisone
Frequency of adrenal crises
Emergency-injection competency

Urgent Referral Criteria

Persistent vomiting
Hypotension
Confusion
Severe weakness
Hypoglycemia
Hyperkalemia
Syncope
Fever or major infection
Inability to retain oral glucocorticoid
Trauma or surgery without adequate stress dosing

Clinical Pearl

Treat suspected adrenal crisis before receiving confirmatory test results.

NPLEX Examination Trap

Do not delay hydrocortisone to perform a stimulation test in a hypotensive, hypoglycemic
patient.

Disease Overview

Primary adrenal insufficiency results from destruction or dysfunction of the adrenal cortex,
causing deficiencies of cortisol and often aldosterone. Increased ACTH causes
hyperpigmentation, while aldosterone deficiency promotes sodium loss, hyperkalemia and
volume depletion.

Most Likely Diagnosis

Endogenous Cushing syndrome

Differential Diagnosis

Exogenous glucocorticoid exposure
Simple obesity
Metabolic syndrome
Polycystic ovary syndrome
Alcohol-associated pseudo-Cushing physiology
Severe depression
Poorly controlled diabetes
Ectopic ACTH syndrome
Adrenal cortisol-producing tumour
Pituitary ACTH-producing adenoma

Key Investigations

● Detailed medication and supplement history
● Repeat first-line cortisol screening using an appropriate method
● ACTH after hypercortisolism is confirmed

Electrolytes and glucose
Bone-density assessment
Pituitary MRI for ACTH-dependent disease when indicated
Adrenal CT for ACTH-independent disease
Inferior petrosal-sinus sampling in selected uncertain ACTH-dependent cases
Evaluation for infection, thrombosis and cardiovascular complications

Gold-Standard Diagnostic Approach

No single screening result should be interpreted in isolation. Diagnosis usually requires
consistent clinical findings and at least two appropriately performed abnormal biochemical
assessments.
Once hypercortisolism is confirmed:
● Low ACTH suggests an adrenal source.
● Normal or elevated ACTH suggests pituitary or ectopic ACTH production.

Conventional Treatment

Surgical removal of the causal pituitary, adrenal or ectopic lesion when feasible
Medical cortisol-lowering therapy when surgery is delayed, unsuccessful or unsuitable
Radiotherapy in selected pituitary disease
Bilateral adrenalectomy in selected refractory cases
Treatment of hypertension, diabetes, osteoporosis, infection and thrombosis risk
Glucocorticoid replacement after successful treatment until
hypothalamic-pituitary-adrenal recovery

Surgical resection of the causal lesion is generally first-line when feasible, alongside
management of cortisol-related comorbidities.

Naturopathic Treatment Plan

Adjunctive treatment may include:

High-quality dietary protein to limit muscle loss
Resistance activity only within fracture and cardiovascular safety limits
Sodium moderation
Diabetes-focused nutrition
Fall prevention
Adequate calcium and vitamin D based on laboratory and bone assessment
Smoking cessation
Sleep and psychological support

Botanical and Supplement Safety

Avoid adrenal glandular products.
Review creams, inhalers and injections for hidden glucocorticoids.
Avoid Glycyrrhiza glabra, which may worsen hypertension and hypokalemia.
Avoid stimulant weight-loss products.
Avoid high-dose calcium when hypercalciuria or nephrolithiasis is present.
Do not attempt to suppress cortisol using unregulated “adrenal balance” supplements.
St. John’s wort (Hypericum perforatum) may alter drug metabolism.

Monitoring

Cortisol testing
Blood pressure
Glucose and HbA1c
Potassium
Weight and waist circumference
Muscle strength
Bone density
Infection
Venous-thromboembolism symptoms
Psychiatric status

Urgent Referral Criteria

Severe hypokalemia
Hypertensive emergency
Psychosis or suicidal risk
Serious infection
Venous thromboembolism
Pathological fracture
Severe uncontrolled diabetes
Acute adrenal insufficiency after treatment

Clinical Pearl

Wide violaceous striae, proximal weakness and easy bruising are more discriminatory for
Cushing syndrome than obesity alone.

NPLEX Examination Trap

Do not order pituitary or adrenal imaging before biochemically establishing cortisol excess.

Disease Overview

Cushing syndrome is the clinical state produced by chronic glucocorticoid excess.
Complications include diabetes, hypertension, osteoporosis, infection, thrombosis, psychiatric
disease and increased cardiovascular mortality.

Most Likely Diagnosis

Catecholamine-secreting right adrenal pheochromocytoma

Differential Diagnosis

Panic attacks
Hyperthyroidism
Hypoglycemia
Carcinoid syndrome
Medication or stimulant exposure
Cocaine or amphetamine use
Pseudopheochromocytoma
Obstructive sleep apnea

● Baroreflex failure
● Menopausal vasomotor episodes

Key Investigations

Plasma free metanephrines or urinary fractionated metanephrines
Careful review of interfering medications and testing conditions
Adrenal CT or MRI after biochemical evidence
Functional imaging for selected multifocal, hereditary or metastatic disease
ECG
Glucose or HbA1c
Renal function
Genetic counselling and testing
Assessment for associated syndromes and additional tumours

Gold-Standard Diagnostic Approach

Biochemical evidence of catecholamine excess should generally be established before
localization imaging, except when an adrenal mass has already been discovered incidentally or
emergency circumstances dictate otherwise.

Conventional Treatment

Specialist multidisciplinary care
Alpha-adrenergic blockade before surgery
Liberalized sodium and fluid intake after adequate alpha blockade when appropriate
Addition of beta blockade only after alpha blockade if tachycardia persists
Surgical adrenalectomy
Perioperative hemodynamic monitoring
Lifelong biochemical follow-up because recurrence or metastatic disease may occur
Genetic evaluation because a substantial proportion are hereditary

Naturopathic Treatment Plan

Before definitive treatment:

Avoid strenuous exercise that provokes attacks.
Avoid dehydration.
Avoid caffeine and stimulant products.
Maintain a symptom and blood-pressure record.
Follow preoperative fluid and sodium instructions from endocrinology.
Seek emergency care for severe or prolonged attacks.

Botanical and Supplement Safety

Avoid:

Panax ginseng
Ephedra sinica
Citrus aurantium
Pausinystalia johimbe
High-dose caffeine
Thyroid glandular products
Sympathomimetic decongestants
Monoamine-oxidase-inhibiting botanicals or drug combinations without review

Monitoring

Blood pressure
Heart rate
Orthostatic symptoms during blockade
Glucose
Plasma or urinary metanephrines
Surgical complications
Recurrence
Family genetic implications

Urgent Referral Criteria

Hypertensive crisis
Chest pain
Acute heart failure
Severe headache with neurological deficit
Arrhythmia
Shock
Seizure
Suspected tumour hemorrhage
Crisis triggered by surgery, anesthesia or medication

Clinical Pearl

Alpha blockade must precede beta blockade in a catecholamine-secreting
pheochromocytoma.

NPLEX Examination Trap

Never biopsy an adrenal mass until pheochromocytoma has been biochemically excluded.

Disease Overview

Pheochromocytoma arises from adrenal-medullary chromaffin cells; related extra-adrenal
tumours are called paragangliomas. Catecholamine secretion can cause episodic hypertension,
arrhythmias, cardiomyopathy and acute vascular emergencies.